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INTRODUCTION 
Respiratory distress is one of the most common cause of admission(30- 40%)  in 
Neonatal Intensive Care Unit and accounts  for  20% of neonatal mortality in India(1). 
Incidence of respiratory distress varies from  0.7 % to 8.3% of live born babies in 
India(2). Babies with respiratory distress are 2-4 times more likely to die than those 
without respiratory distress. It results from a variety of disorders of respiratory and 
non-respiratory etiology. Among them, transient tachypnoea of newborn, respiratory 
distress syndrome and perinatal asphyxia are commonest causes. Although respiratory 
distress may represent a benign, self limited process, it may also be the first sign of 
sepsis or serious cardiopulmonary disease. The overall incidence of respiratory 
distress in term babies is (4.2%). Early diagnosis and management can reduce the 
morbidity and mortality in the neonatal period. 
Identification of the cause of respiratory distress is important for planning and 
provision of facilities for these babies and thereby achieving reduction in neonatal 
mortality. In India only very few studies on cause of respiratory distress in term 
babies are available. Results of such studies are also variable in different centers. 
In this juncture, this study will help us to identify the causes of respiratory distress 
in our centre and determine the strategies to improve the outcomes in these babies. 
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REVIEW OF LITERATURE 
In a study at Birdem titled  “Etiology of Respiratory Distress in Newborn –
Experience in BIRDEM” conducted by Haquea et al(3), out of 562 admitted cases 
192 developed respiratory distress(34%).There was a male predominance with 64% of 
cases being males. Mortality rate in this study was 16.7%. Sepsis (40.6%) was the 
leading cause of death followed by Birth asphyxia(37.3%).The cause of respiratory 
distress was found to be TTN in 83 babies(43.2%), RDS in 58 
babies(30.2%),Perinatal asphyxia in 48 babies(25%),septicemia in 31 babies (16.1%), 
congenital pneumonia in 23 babies(11.9%), CHD in 20 babies(10.4%), MAS in 3 
babies(1.5%) and surgical causes in 4 babies(2.0%).  
In a study by Sirageldin MK Abderlrahman et al(4) at Sudan “Neonatal 
respiratory distress in Omdurman Maternity Hospital”  incidence of respiratory 
distress was 4.83% which constituted 56.5% of the NICU admissions. In this study 
also TTN was the commonest cause of respiratory distress(28%), followed by 
Sepsis(24%), HMD(15%), CHD(9%), MAS(6%), Other causes (18%). In this study 
also males were affected more contributing to 54% of the cases. Overall Mortality rate 
was 36% with HMD(13%) as the leading cause of death followed by Sepsis(8%) and 
congenital heart disease(5%). 
In a study at Basrah by Assel Mohammed Wadi et al(5)  titled “ Respiratory 
Distress in Full Term Neonates in the First Week of Life in Basrah Maternity 
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and Children Hospital” out of 167 cases, it was found that 75 (44.9%) cases were 
due to Transient tachypnea of the newborn  followed by birth asphyxia in 22(13.2%) 
cases; Meconium Aspiration syndrome was found in 16(9.6%) of cases, early sepsis 
in 14(8.4%), and Pneumonia in 13(7.8%). Congenital heart diseases was responsible 
for 3(7.8%) of cases, while Anemia was found in 7(4.2%) of total cases, 
pneumothorax in 5(3%) and Respiratory Distress Syndrome in only 2 (1.2%). Out of 
167 cases , 103 (61%) were male babies and 64(39%) were females. Mortality rate in 
this study was 9%(15 cases). Sepsis(33%) and Birth asphyxia(33%) were the most 
common causes . 
In “A Clinical Study of Respiratory Distress In Newborn and its Outcome” 
study by Santhosh et al(6) at Bangalore out of 553 total admissions 76 were due to 
respiratory distress (13.7%). The etiology being TTN in 35 cases(46%), RDS in 24 
cases(31.5%), Birth asphyxia in 19 cases(25%), pneumonia and sepsis in 19 
cases(25%), MAS in 6 cases(7.8%) , pneumothorax in 2 cases (2.6%) , CHD in 1 case 
(1.3%) and laryngomalacia in 1 case(1.3%). Out of 76 study cases, 6 (7.8%) expired. 
In Keerti Swarnakar et al(7) study of “Neonatal respiratory distress in early 
neonatal period and its outcome” out of 855 NICU admissions, 140(16.3%) were 
due to respiratory distress. The commonest causes of respiratory distress in this study 
were transient tachypnea of newborn (TTN) 57 (40.7%), respiratory distress 
syndrome (RDS) 24 cases (17.2%), birth asphyxia 16 cases (11.4%) and Meconium 
aspiration syndrome (MAS) 13 cases (9.3%). Cesarean section was the most common 
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predisposing factor associated with the development of TTN and RDS (the most 2 
common causes of respiratory distress in this study). The overall mortality rate of 
cases of respiratory distress in this study was 22.86%.  
In Abhijit Dutta et al(8) study titled “Spectrum of Respiratory Distress in 
Newborn: A Study from a Tertiary Care Hospital in Kolkata” 152 NICU 
admissions were due to respiratory distress comprising 6.4% of all inborn admissions 
and 14.15% of sick newborns. Transient tachypnea of the newborn (TTN) was the 
commonest (32.23%) cause of respiratory distress followed by Pneumonia (24.35%), 
MAS (13.15%), Birth asphyxia (12.5%), RDS (7.9%), Cardiovascular (3.3%) and 
surgical causes (2.63%). 
In a study titled Clinical profile of neonates with respiratory distress by Mamta 
Bajad et al(9) Hyaline membrane Disease was found to be the commonest cause of 
respiratory distress followed by Birth asphyxia, Pneumonia, Meconium aspiration 
syndrome, Tracheo-oesophageal fistula, Transient tachypnea of newborn, Congenital 
heart disease and others. Among these Mortality was highest in Hyaline membrane 
disease 93 (35.49%) followed by Birth asphyxia 54 (22.44%), Pneumonia 44 
(18.03%), Congenital heart disease 7 (15.90%), Meconium aspiration syndrome 10 
(13.69%), Tracheo-oesophageal fistula 10 (18.50). 
In a Descriptive Study of Cases of Respiratory Distress in NICU in Ahmed Maher 
Teaching Hospital by Mohd. Zaazou et al(10) the following observations were made.  
The commonest causes of respiratory distress in the study were Transient tachypnea 
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of newborn (TTN) 78 cases (37.9%), Respiratory distress syndrome (RDS) 64 cases 
(31%), Meconium aspiration syndrome (MAS) 21 cases (10.2%), and Perinatal 
asphyxia 15 cases (7.3%).  The study also showed Cesarean section was the most 
common predisposing factor associated with the development of TTN and RDS . The 
overall mortality rate of cases of respiratory distress in the study was 18.9% and 
Cases with Perinatal asphyxia were associated with the highest mortality rate (40%) 
followed by RDS (39%), and MAS (19%). 
In a study conducted by Manas Ranjan Sahoo et al(11)  Clinicoetiological profile 
and risk assessment of newborn with respiratory distress in a tertiary care centre 
in South India , Out of 100 newborns admitted with respiratory distress, 90% were of 
respiratory origin. In that, the most common cause was TTN (32%) but severe distress 
was contributed maximum by HMD (44.82% of severe distress). 
In a study of  Respiratory distress of the term newborn infant by Edwards et 
al(12) showed the increasing number of term infants delivered by elective cesarean 
section has  increased the incidence of respiratory distress in neonates. Additionally 
the risk decreases with each advancing week of gestation. At 37 weeks, the chances 
are three times greater than at 39-40 weeks gestation. 
In a study by Kim et al(13) in term neonates titled Early Neonatal Respiratory 
Morbidities in Term Neonates , A total of 260 term neonates with respiratory 
distress were enrolled in the study. The average gestational age was 38±1.3 weeks, 
while the birth weight was 3,233.7±462.0 g. The most common respiratory disease 
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encountered in term neonates was TTN (n=98, 37.7%), followed by MAS (n=76, 
29.2%), Spontaneous Pneumothorax (n=27, 10.4%), PPHN (n=24, 9.2%), Neonatal 
Pneumonia (n=19, 7.3%), and RDS (n=16, 6.2%). Incidence of TTN and RDS was 
higher in neonates aged <39 weeks than in those aged ≥39 weeks. Higher incidence of 
spontaneous pneumothorax and RDS was observed in neonates delivered before the 
onset of labor. The incidences of TTN, spontaneous pneumothorax, and RDS were 
higher in the elective cesarean section group before 39 weeks of gestation. 
In a study titled Transient tachypnea of the newborn: predictive factor for 
prolonged tachypnea by kasap et al(14) found that Male gender, prematurity and 
delivery by cesarean section were the major risk factors for TTN. Parenteral 
furosemide had no effect on the clinical course of the disease. 
In a study by Ersch J et al(15)  Increasing incidence of respiratory distress in 
neonates. In the 30 years studied, the proportion of infants hospitalized with 
Respiratory distress increased from 1.9% to 3.8% of the whole neonatal population 
and from 30% to 53% of all infants admitted to a neonatal unit. The use of 
Mechanical ventilation decreased from 31% to 16%, nasal CPAP increased from 
almost 0% to 26% and surfactant administration increased from 0% to 53% in infants 
with hyaline membrane disease. Overall mortality decreased in infants with 
Respiratory distress from 15.5% to 3.5%. The incidence of Respiratory distress in 
infants admitted to neonatal units doubled over the last 30 years in a geographically 
defined neonatal population. This rise can predominantly be ascribed to infants with 
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birth weight >2500 g and may reflect the corresponding increase in the rate of 
caesarean section. 
In a study of Neonatal respiratory distress in a reference neonatology unit in 
Cameroon: a retrospective analysis of prevalence, predictors, etiologies and 
outcomes by Tochie et al(16), Out of the 703 newborns included in the study 47.5 % 
of them had  Respiratory distress . Acute fetal distress, elective caesarean delivery, 
APGAR score < 7 at the 1
st
 minute, prematurity, male gender and macrosomia were 
independent predictors of Neonatal Respiratory distress. The major causes were 
neonatal infections (31%) and Transient tachypnea of the newborn (25%). Its neonatal 
mortality rate was 24.5%, mainly associated with neonatal sepsis and hyaline 
membrane disease. 
In a study by Chandrasekar et al(17) titled Clinical study of respiratory distress 
in newborn, Transient tachypnoea of newborn (60%) was the commonest cause of 
newborn respiratory distress. Development of severe distress was more when onset is 
at 6 hours after birth (77%), duration persists more than 24 hours (65.5%) Oxygen 
requirement in number of days increases depending on diagnosis TTN 100% for <1 
day, MAS 95.4% for 2 days and RDS 100% for 3 days. Ventilation was done in 3 
cases and there was no mortality. 
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    RESPIRATORY DISTRESS IN NEONATES 
Respiratory distress is a common manifestation in neonates requiring admission. 
Its significance ranges from a self limiting process due to a delayed adaptation to the 
post natal environment to potentially lethal conditions. The underlying etiology for 
distress may be due to respiratory problem or non respiratory pathologies like 
neurologic, cardiovascular, metabolic, hematologic, or neuromuscular disorders, as 
well as reflection of sepsis, drug withdrawal, and other conditions such as severe 
anemia. A good history to identify the possible risk factors, clinical assessment of the 
newborn with supporting evidence from investigations helps in tailoring the 
management according to the etiology. While general supportive measures, including 
provision of supplemental oxygen, thermal support and provision of adequate fluid 
and calories are common to all newborns with respiratory distress. Specific 
intervention depends on accurate diagnosis. In the majority of infants, the respiratory 
illness will be self limited with full recovery, but management and outcome depend 
heavily on the underlying cause. 
TRANSIENT TACHYPNEA OF NEWBORN 
Transient tachypnea of the newborn (TTN) is the commonest cause of respiratory 
distress in term newborn. It is usually benign, resolving within 24 to 72 hours. Most 
of the affected newborns are born at late preterm or term. It occurs due to delay in the 
clearance of fetal lung fluid(18). The affected newborn presents with tachypnea, 
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minimal or no retractions, and occasionally cyanosis. The distress and decrease is 
oxygen saturation gets alleviated by supplying oxygen with Fio2 <40%.  
EPIDEMIOLOGY: 
The following are risk factors for TTN: 
a) Cesarean section with or without labor  
b) Precipitous labour 
c) Preterm birth (including late preterm ), at earlier gestations other comorbidities   
like  Respiratory distress syndrome (RDS) also occur. 
d) Male gender(19) 
e)  Macrosomia 
f)  Maternal diabetes  
g)  Family history of asthma 
h)  Multiple gestations  
CLINICAL PRESENTATION: 
Onset of distress is within 6 hrs of birth , presenting as increased rate (tachypnea) , 
minimal to no retractions, grunting, nasal flaring and occasionally cyanosis . The 
distress is usually mild to moderate getting alleviated with supplemental oxygen at 
Fio2<40%. Hyperinflation due to airway obstruction and air trapping results in barrel 
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shaped chest. On auscultation bilateral air entry is adequate, crackles may be present. 
Distress starts improving and completely resolved within 12 to 24 hours in mild cases 
and lasts upto 72 hrs in severe cases. 
CHEST X RAY: 
Chest radiography in TTN shows retention of lung fluid especially in the perihilar 
region (sunburst pattern) due to dilated lymphatics, coarse, fluffy densities indicating 
alveolar edema, Hyperinflation with widening of intercostal spaces, fluid collections 
at interlobar fissure, occasionally mild cardiomegaly and mild pleural effusions may 
also occur. The radiological clearance in TTN starts by 12 to 18 hours and complete 
resolution occurs by 48 to 72 hours. This differentiates TTN from meconium 
aspiration and pneumonia. CXR also helps in excluding other etiologies like Lung 
malformations, respiratory distress syndrome and pneumothorax.  
TREATMENT: 
Management is essentially supportive by providing  supplemental oxygen(20), as 
per the requirement.  Severe cases may show response to continuous positive airway 
pressure (CPAP). If distress persists nasogastric feeds or intravenous fluids may be 
needed. Use of Diuretics is not beneficial(21). Although TTN is usually benign, 
supplemental oxygen therapy may result in complications. CPAP is associated with 
increased risk of air leak. TTN is a benign process with no risk of recurrence and 
excellent prognosis. 
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BIRTH ASPHYXIA 
Perinatal asphyxia is one of the commonest cause for neonatal admission and 
contributes to major morbidity and mortality in newborns(22). It is a global problem 
affecting mainly the developing countries. Of the live born babies around 10 % 
require resuscitative efforts and extensive resuscitative efforts are needed only in <1% 
newborns. Following hypoxia the neuronal injury occurs in two phases, a primary 
phase followed by a transient period of recovery with possible therapeutic 
interventions and secondary phase(23). Reperfusion following a period of hypoxia 
also results in reperfusion injury due to free radical generation.  
With improvement in resuscitative measures the proportion of asphyxia leading 
onto Hypoxic ischemic encephalopathy is on decline. Still, 5 to 10 / 1000 live born 
babies suffer from severe HIE and about one fourth of them are left with permanent 
neurological sequelae. 
CLINICAL MANIFESTATIONS: 
Antenatally  IUGR with increased vascular resistance and absent or reversal of end 
diastolic flow on Doppler is the earliest indicator for fetal hypoxia.  
In the intrapartum period, presence of fetal bradycardia and loss of beat-to-beat 
variability occurs in fetal cardiotocograph, Continuous fetal heart monitoring also 
shows variable or late decelerations. Especially in near term babies, these are 
indications for oxygen supplementation to the mother to reduce fetal hypoxia and 
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termination of pregnancy to decrease fetal neurological damage and death. Meconium 
staining of amniotic fluid is an indicator of fetal distress. 
Postnatally, the affected newborn is depressed with a poor tone, absent or weak 
cry and absence of repiratory efforts. In the initial hours this hypotonia continues 
subsequently changing to hypertonia or normal tone. Pallor, cyanosis, apnea, 
bradycardia, and unresponsiveness to stimulation are also signs of HIE. Cerebral 
edema occurs in the the next 24 hours leading onto severe central nervous system 
depression. This results in seizures, which may be difficult to control with the 
conventional anticonvulsants. Although encephalopathy associated with the hypoxia 
is a main reason for seizures in these babies yet hypoglycaemia, hypocalcemia and 
infection should also be considered. 
Other than central nervous system, hypoxia also leads to hypoxic injury of other 
vital organs resulting in multi organ dysfunction. Kidney is the most common organ 
to be involved resulting in acute kidney injury, followed by cardiac failure and 
cardiogenic shock, persistent pulmonary hypertension and gastrointestinal perforation. 
DIAGNOSIS : 
Imaging and electroencephalography are the principal investigations. MRI is 
preferred to CT to delineate the extent of injury(24). Amplitude-integrated 
electroencephalography (aEEG) are useful in predicting the long term outcome(25). 
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This procedure provides useful data in the therapeutic window period hence helpful in 
guiding therapy and prognosis.  
TREATMENT: 
Whole body (systemic) or selective cerebral therapeutic hypothermia reduces 
mortality or major neurodevelopmental impairment in term and near-term infants with 
HIE(26). Systemic hypothermia may result in more uniform cooling of the brain and 
deeper CNS structures, hence reduces neurological damage. But it is associated with 
various complications.  Phenobarbitone is the first line antiepileptic for seizures. 
Phenytoin or lorazepam is used in refractory seizures.  Status epilepticus, multifocal 
seizures and multiple anticonvulsant medications during therapeutic hypothermia, is 
associated with a poor prognosis. 
Managing the multiorgan dysfunction asscociated with the condition is important. 
Hyperthermia leads to adverse neurological outcome hence should be avoided. Other 
supportive measures like adequate ventilation, BP, pH should also be ensured. Use of 
antibiotics to control infections is also needed. 
PROGNOSIS:  
The outcome of HIE, varies from complete recovery in milder cases to severe 
neurological damage and death in severe cases. The result of investigations like MRI 
and EEG are also useful in predicting prognosis.  All survivors of moderate to severe 
HIE should be followed up for neurodevelopmental problems.  
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MECONIUM ASPIRATION SYNDROME 
The passage of meconium in utero occurs in the setting of acute or chronic 
hypoxia and/or infection.This can result in aspiration of meconium in the intrapartum 
or postpartum period, by the gasping fetus or newborn respectively(27). Meconium-
stained amniotic fluid is found in 10-15% of births and usually occurs in term or 
postterm infants. Meconium aspiration syndrome (MAS) develops in 5% of such 
infants(28); 30% require mechanical ventilation and  3-5% die. Meconium causes 
lung injury by stimulation of cytokines and release of inflammatory mediators(29). 
Aspirated meconium also causes inhibition of surfactant function(30). The infants are 
meconium stained and may be depressed and require resuscitation at birth. 
CLINICAL MANIFESTATIONS: 
Respiratory distress within the first few hours of birth, which manifests as 
increased respiratory rate, retractions, grunting, and cyanosis in severely affected 
newborns. Partial obstruction of airways causes air trapping by ball valve mechanism 
which may result in air leak syndromes. Hyperinflation of certain areas of the lung 
may lead to overdistended barrel shaped chest. Mild to moderate cases improves 
within 72 hrs, but when the disease is severe requiring mechanical ventilation, it 
carries a high risk for mortality. Tachypnea may persist for several days or even 
weeks.  
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CHEST RADIOGRAPH: 
The classic roentgenographic findings are Diffuse, asymmetric patchy 
infiltrates,areas of consolidation, often worse on the right, Hyperinflation and 
Flattening of the diaphragm. A normal chest radiograph in a newborn with severe 
hypoxia with no cardiac anomaly should arouse the suspicion of pulmonary 
hypertension. 
PREVENTION OF MAS: 
Risk factors for mecoinum aspiration include: 
1. Pre-eclampsia 
2. Chronic diseases affecting cardiovascular or respiratory system. 
3. Small for gestational age 
4. Post term pregnancy. 
Monitoring of all high risk mothers for fetal well being is essential for early 
identification of meconium passage.The risk of meconium aspiration may be 
decreased by rapid identification of fetal distress and initiation of prompt delivery.  
TREATMENT OF MAS: 
Treatment of the MAS includes supportive care and oxygen therapy for respiratory   
distress. 
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Oxygen Supplementation: Free flow oxygen given in mild cases 
CPAP: When the requirement of Fi02 exceeds beyond 40%, CPAP should be 
considered. CPAP is useful in reducing the distress, but the pressures must be tailored 
for each baby as CPAP may aggravate air trapping increasing the risk of air leak 
syndromes. 
Mechanical ventilation: Babies with severe disease often require mechanical 
ventilation. While ventilating a baby with MAS high Peak inspiratory pressures are 
needed. PEEP should be minimum and expiratory time must be adequate to decrease 
the air trapping. 
Extracorporeal membrane oxygenation (ECMO) may be needed for babies with 
refractory respiratory failure. 
Surfactant: Meconium inhibits surfactant activity. Surfactant instillation may 
improve oxygenation and reduce pulmonary complications and the need for 
ECMO(31). But routine use of surfactant to treat MAS is not advised. However, it 
may be helpful in babies detoriating  inspite of standard therapy.  
COMPLICATIONS: 
Air leak syndromes (Pneumothorax or pneumomediastinum) complicate around  
15% to 30% of babies with Meconium aspiration syndrome. Chances of air leak are 
increased by CPAP and Mechanical ventilation. Persistent pulmonary hypertension of 
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newborn complicates around 30% cases and increases the mortality associated with 
MAS. 
PERSISTANT PULMONARY HYPERTENTION OF NEWBORN 
Persistent pulmonary hypertension of the newborn (PPHN) is a condition that 
occurs due to defect in the transition from fetal circulation to neonatal circulation 
resulting in increased pulmonary resistance with right to left shunt across foramen 
ovale or ductus arteriosus(32). This persistence of fetal circulation results in decrease 
in blood flow  to  lungs and thereby decreases oxygenation at the pulmonary vascular  
bed  resulting in  systemic hypoxia. 
EPIDEMIOLOGY: 
Term and post term babies are at risk of developing Persistent pulmonary 
hypertension of the newborn (PPHN). The incidence ranges from  1/500 to 1,500 live 
birth. Risk factors are Perinatal asphyxia, Meconium aspiration, EOS, Respiratory 
distress syndrome, hypoglycemia, polycythemia, use of drugs like NSAIDS(33), 
SSRIs in third trimester leading to constriction of the ductus arteriosus , and 
pulmonary hypoplasia associated with anomalies like CDH, Potters sequence etc. 
PPHN is mostly idiopathic. But few may have decrease in levels of arginine and nitric 
oxide with a likely etiology of defect in the synthesis of nitric oxide(34).  
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CLINICAL MANIFESTATIONS: 
In PPHN, onset of distress is usually immediately following birth or within the 
first 12 hours of life. Depending on the likely etiology the newborn may have severe 
cyanosis and increased respiratory rate with minimal retractions as in the case of 
polycythemia, hypothermia, hypoglycemia or marked distress in the form of grunting, 
nasal flaring, retractions and shock in cases of MAS, CDH, Hypoplasia of lung. The 
resultant myocardial dysfunction may culminate in cardiogenic shock. Hypoxia is 
usually more severe than expected. 
DIAGNOSIS: 
PPHN must be a differential diagnosis whenever a cyanotic baby is investigated. 
A. The other possible differentials of a cyanotic newborn include Congenital heart 
disease, Parenchymal lung disease and Sepsis. 
B. The affected newborn usually presents with respiratory distress and cyanosis. 
Some may show difference in extent of cyanosis in the preductal and postductal 
regions. Precordial pulsations, systolic murmur of TR, accentuated S2 are other 
findings in PPHN. 
C. A PaO2 or SpO2 gradient of 10% or more between preductal (right upper limb) 
and postductal (lower extremity) indicates right to left shunt. Ruling out structural 
lesions in such a situation points to likelyhood of PPHN.  
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D. CXR is either normal or reveals the associated anomalies like pulmonary 
hypoplasia. 
E. An echo is mandatory to demonstrate right to left shunting and rule out structural 
anomaly.  
TREATMENT 
PPHN is an emergency needing urgent measures to correct hypoxia and improve 
perfusion to lungs. Failure to achieve this results in multiorgan dysfunction. Providing 
supportive measures helps in transition from the fetal circulation to neonatal 
circulation.  
Supplemental oxygen: Oxygen supplementation forms the mainstay of therapy to 
decrease the pulmonary vascular resistance. Maintaining saturation between 90 to 
98% provides adequate oxygenation avoiding the ill effects of hyperoxia. 
Intubation and mechanical ventilation: Indications for mechanical ventilation in 
PPHN are: Persistent hypoxia inspite of maximum oxygen supplementation, 
Respiratory failure as evidenced by increased Paco2 and decreased pH. Since the 
disease course is labile and outcome is variable, careful tapering of oxygen support is 
essential.The ventilator settings are adjusted, based on the underlying pathology 
leading to PPHN.In diseases involving the lung parenchyma, High-frequency 
oscillatory ventilation (HFOV) or high-frequency jet ventilation (HFJV) is preferred 
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especially in MAS. Also HFO plays a useful role in giving nitric oxide therapy in 
such cases(35). 
Inhaled nitric oxide: Nitric oxide is synthesized by the vascular endothelium. 
Inhaled nitic oxide exerts its effect at the pulmonary vasculature causing its dilation 
with minimal or no systemic effect, thereby decreasing pulmonary vascular resistance 
selectively. It is also useful in reducing the need for extracorporeal membrane 
oxygenation. Methemoglobinemia is a serious toxicity at higher doses.Another 
serious complication observed is rebound hypoxia which occurs in case of sudden 
discontinuation of nitric oxide rather than tapering and stopping the drug after 
ensuring adequate oxygenation with minimal dose of iNO  and Fio2 < 50% (36).  
ECMO:  Its is a life saving treatment in around 75 to 85% cases carrying good 
prognosis even in cases failed to improve with inhaled nitic oxide therapy. 
PROGNOSIS: 
Survival depends on the pathology underlying the development of persistent 
pulmonary hypertension on newborn, associated conditions and the need for ECMO. 
CONGENITAL HEART DISEASE 
Congenital heart disease (CHD) is one of the commonest reason for admission to 
NICU with incidence upto  8 /1,000 live births(37) and leads to morbidity and 
mortality in the newborn. About 15% of these lesions are lethal in the newborn period 
itself.  
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Congenital heart diseases are classified into: 
1. Acyanotic Congenital heart diseases and 
2. Cyanotic congenital heart diseases (CCHD) 
CCHD are further subdivided into diseases with: 
a. Normal to increased blood flow to the lung flow with intracardiac mixing 
(complete or incomplete) and 
b. Decreased pulmonary blood flow with intra cardiac right to- left shunt 
CLINICAL EVALUATION: 
Onset of symptoms varies in different cardiac lesions, being influenced by the 
changes occurring in the circulation after birth. Some lesions may not be evident 
before discharge. Hence identifying these conditions early is a difficult task. Many 
findings of cardiac disease like hypotension, hypoxia etc may also occur as a 
complication of various newborn conditions, making the diagnosis even more difficult 
especially in preterm babies. 
Few symptoms pointing to cardiac illness include: Respiratory distress in the form 
of increased rate, retractions, difficulty in feeding in the form of suck rest suck cycle, 
forehead sweating, and lethargy. Cyanosis is evident in cyanotic heart diseases, pallor 
may also be present in certain conditions. Weight gain is poor in these babies. These 
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symptoms are non specific and are not pathognomonic of cardiac lesions alone, and in 
three fourth of the newborns, these symptoms doesn’t occur.  
Cyanosis is an important finding of cyanotic heart disease but is difficult to 
appreciate in first 2 days of life as well as in darkly pigmented newborns. Pulse 
oximetry is useful in such cases, with a post ductal oxygen saturation <95% indicating 
the possibility of CHD. 
Respiratory disorders also result in central cyanosis making the distinction of these 
two conditions difficult. The hyperoxia test(38) is valuable in ruling out pulmonary 
disorders and establishing an underlying cardiac disorder.  Decreased respiratory 
drive from CNS due to diseases like Hypoxic ischemic encephalopathy may also 
result in cyanosis due to hypoxemia.  
MANAGEMENT:  
Establishing the diagnosis early is vital for provision of immediate measures like 
PGE1 which increases the likely hood of survival(39). Diagnosis is based on clinical 
suspicion, Chest Radiograph, Electrocardiography and Echocardiography. Treatment 
is essentially guided by the underlying cardiac pathology. Supportive measures, 
supplemental oxygen, antifailure measures if needed and planning for surgery are the 
treatment options for cardiac disease. 
 
 
23 
 
NEONATAL SEPSIS 
Sepsis complicates almost all disease process affecting the newborn and is a major 
cause for neonatal morbidity and mortality. 
TYPES: 
Based on the onset it is categorised into  
I. Early onset Sepsis (EOS) - onset within 72 hours ( some studies upto 7 days) 
of life.  
II. Late Onset Sepsis.(LOS) - after 4th or 8th day of life. 
This is important to suspect the possible risk factor and thereby the organisims 
leading to sepsis and helps in choosing the appropriate antibiotic regimen. 
EOS is mostly due to maternal vaginal flora and the perinatal risk factors, whereas 
LOS is mostly due to environmental factors leading to infection by hospital or 
community acquired organism(40). Hence the pathogens leading to sepsis varies with 
time. Till few years ago, Strep. pneumoniae and Group A streptococcus were the most 
common organisms causing sepsis. This has changed and Group B streptococcus and 
E.coli are the common pathogens at present(41). These are the likely organisms in 
most of the developed countries, data regarding developing countries are lacking but 
Group B streptococcus is less common whereas Klebsiella species and 
Staphylococcus aureus are the more likely pathogens in developing world.  
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CLINICAL MANIFESTATIONS: 
There is no typical feature for sepsis. The manifestations are nonspecific: 
i. Fever or Hypothermia 
ii. Poor feeding / Lethargy 
iii. Irritable / Inconsable cry 
iv. Respiratory distress and apnea 
v. Vomiting and Jaundice 
These features may also be present in encephalopathy and inborn errors of 
metabolism also making the exact diagnosis of sepsis difficult in regions with poor 
lab facilities. Definition of sepsis is by presence of bacteremia in blood culture. Other 
infectious foci like pneumonia, meningitis and UTI may also be present.  
Presence of risk factors and symptoms suggesting of sepsis point towards the 
diagnosis. Maternal fever, chorioamnionitis, PROM, maternal UTI suggest EOS. 
Premature and low birth weight babies succumb to sepsis more often. 
DIAGNOSIS: 
Blood culture showing bacteremia is the gold standard. But it lacks sensitivity. 
Additional lab investigations for sepsis are: C reactive protein, ESR, leucocyte count, 
ANC, platelet count,band ratio etc. 
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TREATMENT: 
On identifying the risk factors, Empiric treatment is initiated, sepsis screen 
investigations are sent and antibiotics are continued till the results turn out to be 
negative. The most common antibiotic regimen for empirical treatment includes 
Ampicillin and an Aminoglycoside which provides effective coverage against both 
Gram-positive and Gram-negative organisms, hence showing good response for the 
common etiological agents. Empirical antibiotic regimen should be decided according 
to the common agents prevalent in the particular region. Antibiotics are changed 
according to the sensistivty pattern once the culture reports are available. Strategies 
should be applied at the antepartum, intra partum and postnatal levels for effective 
control of infection(42). 
NEONATAL PNEUMONIA 
Pneumonia is a killer disease and contributes to majority of the neonatal mortality  
globally(43). It may also result in stillbirth. The causative agent primarily differs 
based on the time of acquisition of infection. In the early neonatal period Gram 
positive organisms are the most common cause for pneumonia mainly Group B 
streptococci, whereas in the late neonatal period by Gram negative organisms like 
E.coli,klepsiella pneumoniae(44). 
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The severity of pneumonia is related to the time of acquisition and birth weight. 
Pneumonia with onset in early neonatal period and those occurring in low birth 
weight babies are more severe with high mortality rates(45). 
EPIDEMIOLOGY OF NEONATAL PNEUMONIA:  
Based on the time of onset pneumonia is categorised into  
I. Early onset pneumonia (<7 days) and  
II. Late onset pneumonia (>7 days) 
Maternal infection spreads across the placenta to the fetus or the organisms present 
in the amniotic fluid enters the lungs as the fetus aspirates the fluid during delivery. 
TORCH infections, TB, Retrovirus and Listeria can also spread from the mother to 
the fetus.  Thus the organisms which gained entry into the lungs, colonize, replicate 
and establish infection leading onto Pneumonia.  
ETIOLOGY: 
Early onset neonatal pneumonia:  Pneumonia occurring in the first week of life is 
usually a result of maternal infection like chorioamnionitis or aspiration of amniotic 
fluid containing the infectious agent leading to invasion of the lungs by the infectious 
organisms resulting in pneumonia. Hence organisms in maternal genitourinary tract  
like  Group B Streptococcus,  Staph aureus and S. pneumoniae are the most common 
organisms causing early onset pneumonia. 
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DIAGNOSIS: 
Respiratory distress with onset in early neonatal period manifesting as increased 
repiratory rate, SCR, ICR, expiratory grunt , chest indrawing and dyspnea  with 
features suggesting sepsis like refusal of feeds, lethargy, diminished DTR , sluggish 
neonatal reflexes, temperature instability should arouse the likelyhood of infectious 
etiology for the respiratory distress possibly pneumonia. CXR findings suggesting 
pneumonia include consolidation of a lobe or segment of the lung, patchy infiltrates, 
air bronchogram and haziness of lung. Some of the findings may also occur in TTN, 
RDS etc, but the persistence of these findings and no radiological clearance within 48 
hrs, suggest pneumonia.  
TREATMENT: 
Empirical antibiotics must be initiated till the culture sensitivity reports are 
available.  
Antibiotics:  A combination of penicillin (Ampicillin- 50mg/kg bd) and 
aminoglycoside (gentamicin- 5mg/kg od).  
Oxygen : Oxygen supplementation is essential when there is hypoxemia(46). Fio2 
should be titrated based on saturation to avoid hypoxic as well as hyperoxic injury. 
Fluid: Since the affected newborns may be sick and direct feeding may be difficult, 
intravenous fluids and gavage feeding are needed till stabilisation. 
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Mechanical ventilation and CPAP: Severe cases may not respond to supplemental 
oxygen and require Continuous positive airway pressure or Mechanical ventilation.  
RESPIRATORY DISTRESS SYNDROME 
Respiratory distress syndrome is a condition mostly affecting preterm babies. 
Gestational age is the major risk factor, lesser the gestational age more the risk and 
vice versa. Next important determinant is birth weight, which also bears an inverse 
relation with ELBW and VLBW babies being more susceptible. 
The risk percentage for gestational age is as follows: 
I. <28 wk   - 60 to 80% 
II. 32-36wk - 15  to 30%  
III. >37 wk   - rare. 
Other risk factors are: Gestational diabetes, multiple pregnancy, LSCS, perinatal 
asphyxia, precipitous delivery, cold stress, and history of sibling previously affected. 
Respiratory distress syndrome occurs due to deficiency of surfactant in the lung. 
Surfactant is the substance which lowers the surface tension at alveoli and prevents 
collapse of the lung. Out of the 4 Surfactant- associated proteins (A to D), B (SP-B) 
and to a minimal extent (SP-C) are vital for adequate surfactant function. Rarely 
mutations affecting these surfactant proteins( B and C)(47) and ATP-binding cassette 
transporter A3 (ABCA3) genes result in lethal form of Respiratory Distress Syndrome 
in term infants. 
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CLINICAL MANIFESTATIONS: 
Onset is within 6 hrs of life or sometimes later and presents as Increased 
respiratory rate, SCR and / or ICR, Nasal flaring, Grunting, Cyanosis in preterm 
newborns. The distress worsens in the initial 24 hours followed by stabilization and 
recovery within 72 to 96 hours, which is heralded by spontaneous diuresis(48). 
Therapeutic intervention modifies this natural course. 
DIAGNOSIS: 
Diagnosis is established by clinical manifestations, typical chest radiograph 
picture and ABG. Typical chest radiograph findings include; 
1. Reticulo nodular pattern. 
2. Air bronchogram 
3. Ground glass appearance / white out lung. 
Initial hypoxia is followed by hypercarbia and variable metabolic acidosis. 
PREVENTION: 
i.   Avoiding early term and near term elective section. 
ii. Suspecting lung immaturity and administration of therapies to improve the lung 
maturity. 
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iii. Antenatal corticosteroids should be  administered to pregnant mothers  with < 34 
week gestational age to decrease the incidence of RDS and death associated with the 
condition(49). 
TREATMENT:  
Treatment is based on the severity of the disease. 
Mild cases              :   Supportive therapy and oxygen supplementation. 
Moderate to severe cases       :   CPAP and Surfactant therapy. 
Continuous positive airway pressure (CPAP) delivers constant pressure and 
thereby maintains the functional residual capacity of the lung. This decreases the 
chance of occurence of atelectasis and also reverses microatelectasis. 
Surfactant therapy is indicated for babies with severe distress who require 
mechanical ventilation and for extremely preterm babies (GA< 28 wks), Surfactant is 
given by INSURE technique. Term babies may also require surfactant as in case of 
infant of diabetic mother and meconium aspiration syndrome in which surfactant 
function is deficient. Recent studies support the administration of CPAP alone without 
surfactant instillation for the treatment of RDS. The results are comparable to those 
receiving mechanical ventilation and surfactant. Hence role of CPAP is promising in 
resource poor settings. 
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PROGNOSIS: 
Prognosis is determined by various factors. 
I. Gestational age: More the gestational age better the outcome.  
II. Occurrence of other comorbid conditions leading to RDS like: Gestational 
diabetes, perinatal asphyxia, MAS etc.  
III. Other complications of preterm infants like hypoglycaemia, hypocalcemia, 
sepsis etc.  
IV. Mortality as a result of Respiratory Distress Syndrome is relatively low, most 
of the times, death occurs due to other complications affecting the preterm 
babies like sepsis, IVH or pulmonary hemorrhage. 
CONGENITAL DIAPHRAGMATIC HERNIA 
CDH is a condition characterised by herniation of abdominal contents through a 
defect in the diaphragm into the chest and associated hypoplasia of the lung.  
This is due to defect in embryogenesis when the structures forming diaphragm are 
not formed adequately or fail to fuse resulting in defect in diaphragm. Since the 
abdominal viscera herniated into the chest, development of lung is disturbed due to 
the mechanical effect of the intestines, resulting in hypoplasia of the lung which is the 
major reason for the morbidity and mortality associated with the condition.  
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EPIDEMIOLOGY:  
Incidence is around 1 per 2500 to 3000 live births. It also carries chances of 
recurrence into the subsequent pregnancies. Left side (80 to 90%) is affected more 
than the right side. Male and female are equally affected but right side defect found to 
be more common in males(50). 
Types of diaphragmatic hernias:  
i. The posterior Bochdalek hernia (95%)   
ii. The anterior Morgagni hernia (5%) 
CLINICAL MANIFESTATIONS:  
Onset of distress is usually immediately following birth. On auscultation there is 
decreased air entry on the affected side with shifting of mediastinal contents to 
opposite side. At times bowel sound may be heard on the affected side which is 
specific for the condition. As the abdominal contents herniated into the thorax, 
abdomen appears scaphoid. 
DIAGNOSIS:  
Diagnosis is established by the clinical findings and xray findings. Chest Xray 
shows bowel in the chest but if air hasn’t entered the bowel, a water density mass with 
mediastinal shift is seen. 
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TREATMENT:  
Providing oxygen by endotracheal intubation and mechanical ventilation is 
essential. Bag and mask ventilation and CPAP must be avoided as air entering the 
intestines during the procedure worsens the condition. A naso- or oro-gastric tube is 
rapidly placed for gastric decompression. 
CDH is no longer considered a surgical emergency, as the basic reason for 
morbidity and mortality is hypoplasia of the lung which is not reversed by surgery. 
Attempting surgery immediately after birth when the newborn is not even  
hemodynamically stable,  increases the chances of death. Hence recently, Surgery is 
adviced after 3 to 7 days after stabilising the newborns general condition for a better 
outcome(51,52). 
EXTRAPULMONARY AIR LEAKS 
Airleak syndromes include pneumothorax, pneumopericardium, 
pneumoperitoneum and pneumomediastinum. Of these symptomatic pneumothorax, 
usually unilateral is more common with an incidence of 1 to 2 % which further 
increases with MAS, RDS and mechanical ventilation (53). 
CLINICAL MANIFESTATIONS 
Clinical manifestations are sudden onset respiratory distress, with diminished 
breath sounds and hyper resonance on the affected side. The heart is displaced toward 
34 
 
the unaffected side, leading to shifting of apical impulse. Transillumination is a useful 
bedside test for diagnosing the condition.  
DIAGNOSIS 
In suspected newborns diagnosis is confirmed by chest Xray, with the edge of the 
collapsed lung standing out in relief against the pneumothorax; pneumomediastinum 
is signified by hyperlucency around the heart border and between the sternum and the 
heart border. 
TREATMENT 
Mild, asymptomatic cases can be managed   conservatively. In severe cases 
causing respiratory  or cardiovascular compromise, emergency aspiration using a soft 
small catheter introduced with a needle is indicated (53). Either immediately or after 
catheter aspiration, intercostal tube insertion should be done or air drained into the 
underwater seal. 
A pneumopericardium requires urgent evacuation of entrapped air. Severe 
localized interstitial emphysema may respond to selective bronchial intubation. 
Judicious use of sedation in an infant fighting a ventilator may reduce the risk of 
pneumothorax (54).  
 
 
35 
 
STUDY 
TITLE: 
A STUDY OF RESPIRATORY DISTRESS IN TERM NEONATES IN EARLY 
NEONATAL PERIOD  
AIMS AND OBJECTIVES: 
OBJECTIVE: To identify the etiological factors of respiratory distress in early 
neonatal period and its immediate outcome. 
DESIGN:     A Descriptive study. 
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MATERIALS AND METHODS: 
STUDY AREA:    
Sick NeoNatal Ward, Department of Neonatology, Govt Theni Medical College 
Hospital 
STUDY POPULATION:  
Inclusion Criteria: 
1. Full term neonates with respiratory distress GA(>37 wks) 
2. Both Inborn and Outborn 
Exclusion Criteria: 
Age at admission >7 days 
STUDY DURATION:  
August 2015 to July 2016 
METHODOLOGY: 
  Full Term (Gestational Age 37 weeks and above) Neonates (both inborn and 
outborn) admitted in SNN Ward of GOVERNMENT THENI MEDICAL COLLEGE 
HOSPITAL, within the above specified period, with respiratory distress, will be 
consecutively recruited into the study after getting informed consent from the parents. 
Respiratory distress is defined as presence of any two of the following features: 
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1.Respiratory Rate  >60/min. 
2.Subcostal /intercostal retractions. 
3. Expiratory grunt. 
Severity is assessed using  Downe’s scoring: 
SCORE 0 1 2 
Respiratory rate <60 60-80 >80/apneic episode 
Cyanosis None In room air In 40% oxygen 
Retractions None Mild Moderate to severe 
Grunting None 
Audible with 
Stethoscope 
Audible without 
Stethoscope 
Air entry Clear Decreased Barely audible 
 
At birth, weight is recorded and a detailed physical examination is performed to 
detect congenital anomalies.  
A special questionnaire is designed for the purpose of the study. The following 
information will be taken: name, age at admission, sex, date of admission and date of 
discharge or death.  
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Neonatal data includes: body weight, gestational age according to the date of last 
menstrual period of the mother antenatal ultrasound or New Ballards score. 
Factors related to labor and delivery assessed includes: Mode of delivery (vaginal or  
LSCS or assisted), place of delivery (Inborn or Outborn), complications (prolonged 
rupture of membranes >18 hr, prolonged labor>18hrs, meconium staining of liquor, 
antepartum hemorrhage and others) 
Maternal information recorded includes: age (high risk group≤18 yr or ≥35 yr and low 
risk group 19-34 yr), parity (which is divided into risk group=P0 or ˃P4 and normal 
group = P1-4), any medical disease complicating pregnancy. This information will be 
reviewed retrospectively from the clinical records. 
The final diagnosis of clinical conditions producing respiratory distress will be based 
mainly on careful scrutiny of the history, clinical and radiological findings. 
INVESTIGATIONS: 
Chest X ray is done in all cases. Complete blood counts, CRP, Blood-Culture and 
Sensitivity and Echo in relevant cases. 
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RESULTS AND OBSERVATION 
TABLE 1   :  INCIDENCE   
VARIABLE NUMBER 
TOTAL NO. OF ADMISSION 2152 
RESPIRATORY DISTRESS IN TERM 655 
INCIDENCE 30.4% 
    
Out of 2152 cases admitted during the study period, 655 term newborns were 
admitted with respiratory distress. The incidence is 30.4%. 
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Fig.1 : INCIDENCE
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TABLE 2: ETIOLOGY OF RESPIRATORY DISTRESS (n=655) 
ETIOLOGY NUMBER PERCENTAGE 
TTN 242 36.95 
BIRTH ASPHYXIA 144 21.98 
MAS 93 14.20 
CHD 78 11.91 
SEPSIS&PN 73 11.14 
RDS 1 0.16 
SURGICAL 7 1.07 
OTHERS 24 2.59 
TOTAL 655 100 
 
In the total 655 cases, TTN was the commonest cause of respiratory distress found 
in 242 cases(36.95%), Birth asphyxia was the second common cause found in 144 
cases(21.98%), followed by MAS in 93 cases(14.2%), CHD in 78 cases(11.91%), 
Sepsis and Pneumonia in 73 cases (11.14%), RDS in 1 case(0.16%), 7(1.07%) were 
due to surgical causes and other causes were found in 17 cases(2.59%). 
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TABLE 3: DISTRIBUTION OF CONGENITAL HEART DISEASES 
CAUSE NUMBER PERCENTAGE 
ASD 21 26.92 
VSD 8 10.26 
PDA 37 47.44 
CYANOTIC 12 15.38 
TOTAL 78 100 
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   Out of the 78 babies with Congenital heart disease, PDA was the commonest cause 
found in 37 babies (47.44%), ASD was found in 21 babies (26.92%), VSD was found 
in 8 babies (10.26%) and Cyanotic heart diseases were found in 12 cases (15.38%). 
 
TABLE 4: DISTRIBUTION OF SURGICAL CAUSES 
CAUSE NUMBER PERCENTAGE 
CDH 1 14.29 
CL&CP 3 42.85 
TEF 1 14.29 
CHOANAL 
ATRESIA 2 28.57 
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    Out of the 7 surgical causes, 1 was CDH, 3 were Cleft lip and cleft palate, 1 was 
Tracheo-esophageal fistula and 2 were Choanal Atresia. 
 
 TABLE   5: DISTRIBUTION OF OUTCOME (n=655) 
OUTCOME NUMBER PERCENTAGE 
DISCHARGE 596 90.99 % 
DEATH 59 9.01 
TOTAL 655 100% 
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Out of 655 term newborns with respiratory distress 596 were discharged, 59 died. 
Mortality being 9.09%. 
 
TABLE 6: ETIOLOGYWISE DISTRIBUTION OF DISCHARGE: (n=596) 
ETIOLOGY TOTAL  DISCHARGED PERCENTAGE
E TTN 242 242 100 
BIRTH 
ASPHYXIA 
144 114 79.17 
MAS 93 76 81.72 
CHD 78 74 94.87 
SEPSIS&PN 73 70 95.89 
RDS 1 1 100 
SURGICAL 7 6 85.71 
OTHERS 17 13 76.47 
TOTAL 655 596 90.99 
DEATH
59
9%
DISC
596
91%
Fig.5 : OUTCOME
DEATH
DISC
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Out of the total 655 cases admitted, 596 were discharged. All the 242 cases of 
TTN were discharged, 114 out of 144 Birth asphyxia cases, 76 out of 93 MAS cases, 
74 out 78 CHD cases, 70 out of 73 Sepsis and pneumonia cases, 1 RDS case, 6 out of 
7 cases due to surgical causes and 13 out of 17  cases due to Other cases were 
discharged. 
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TABLE 7: ETIOLOGY WISE DISTRIBUTION OF DEATH (n=59) 
ETIOLOGY DEATH PERCENTAGE 
TTN 0 0 
BIRTH ASPHYXIA 30 50.85 
MAS 17 28.81 
CHD 4 6.78 
SEPSIS & PN 3 5.08 
RDS 0 0 
SURGICAL 1 1.69 
OTHERS 4 6.79 
TOTAL 59 100 
 
Out of total 655 cases included in the study, 59 died with a mortality rate of     
9.09 %. Birth asphyxia was the main cause for mortality contributing to 50 % deaths. 
MAS was the second common cause for mortality found in 28% cases. CHD was the 
cause of death in 6.7%cases, Sepsis and Pneumonia were found as the cause of death 
in around 5% cases, surgical causes in 1.6% and other causes were found in 6.79% 
cases. 
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TABLE 8: CASE FATALITY RATE  
 
ETIOLOGY TOTAL DEATH CFR 
TTN 242 0 0 
BIRTH 
ASPHYXIA 
144 30 20.83 
MAS 93 17 18.28 
CHD 78 4 5.13 
SEPSIS&PN 73 3 4.10 
RDS 1 0 0 
SURGICAL 7 1 14.28 
OTHERS 17 4 23.52 
TOTAL 655 59 9.09 
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Out of 242 TTN cases admitted, all the cases were discharged and no death was 
found, with  CFR of 0%. Highest Case fatality rates were associated with Birth 
asphyxia (20.83%), Pneumonia(22.22%) , Surgical causes(14.28%) and other 
causes(23.52%). Case fatality rate in MAS was 18.28% and CHD was 5.13%. 
 
TABLE 9: GENDER DISTRIBUTION OF NEONATES(n=655) 
GENDER NUMBER PERCENTAGE 
Male 416 63.53 
Female 239 36.47 
Total 655 100 
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Out of 655 term newborns with respiratory distress 416 were male, 239 were 
female. There is a male preponderance. 
 
Table 10  :ETIOLOGY WISE GENDER DISTRIBUTION(n=655) 
ETIOLOGY MALE FEMALE 
TTN 153 89 
BA 86 58 
MAS 64 29 
CHD 50 28 
SEPSIS&PN 48 25 
RDS 1 0 
SURGICAL 5 2 
OTHERS 9 8 
TOTAL 416 239 
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Out of the 242 TTN cases 153 were males 89 were females with a male 
preponderance. In Birth asphyxia 86 were males, 58 were females. In MAS 64 were 
males, 29 were females. In CHD 50 were males 28 were females. In Sepsis and 
Pneumonia 48 were males and 25 were females, 5 were males and 2 were females in 
surgical causes. In RDS 1 was male. Other causes for distress were found in 9 males 
and 8 females. 
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TABLE 11: DISTRIBUTION OF RESPIRATORY DISTRESS BY 
GESTATIONAL AGE (n=655) 
GESTATIONAL AGE No. PERCENTAGE 
37-38 wks(ET) 346 52.94 
≥39 wks(LT) 309 47.06 
Total 655 100 
 
Out of the 655 term cases, 346 were early term and 309 were late term with more    
cases of respiratory distress in early term. 
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TABLE 12: ETIOLOGY WISE DISTRIBUTION OF RESPIRATORY 
DISTRESS BY GESTATIONAL AGE (n=655) 
ETIOLOGY EARLY TERM LATE TERM 
TTN(242) 133 109 
BIRTH 
ASPHYXIA(144) 
68 76 
MAS(93) 33 60 
CHD(78) 53 25 
SEPSIS&PN(73) 42 31 
RDS(1) 1 0 
SURGICAL(7) 4 3 
OTHERS(17) 12 5 
TOTAL(655) 346 309 
 
Out of the 242 TTN cases, 133 were early term and 109 were late term, out of 144 
birth asphyxia cases, 68 were early term and 76 were late term, out of 78 CHD  cases, 
53 were early term and 25 were late term, out of 73 sepsis and pneumonia cases 42 
were early term and 31 were late term, out of 7 cases due to surgical causes 4 were 
early term and 3 were late term , In RDS 1 case was early term, out of 14 cases due to 
other causes 12 were early term and 5 were late term. Thus TTN, CHD, SEPSIS and 
surgical causes were common in early term. BA and MAS were common in late term. 
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TABLE 13: WEIGHT DISTRIBUTION OF NEONATES (n=655) 
BIRTH WEIGHT No. PERCENTAGE 
<2.5  or >4 KG 135 20.67 
2.5 – 4 KG 520 79.33 
TOTAL 655 100 
 
Out of the total 655 cases, 135 babies (20.67%) had a birth weight < 2.5 kg or       
> 4 kg. 520 babies (79.3%) had birth weight between 2.5 to 4 kg. 
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TABLE 14: MODE OF DELIVERY 
MODE NO. PERCENTAGE 
LSCS 341 52.06 
VAGINAL 
(LN+FORCEPS) 314 47.94 
TOTAL 655 100 
 
Out of the total 655 cases, 341 were delivered by LSCS (52.06%) and 314 cases 
were delivered by vaginal delivery ( 47.94%), with more LSCS cases. 
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TABLE 15:  ETIOLOGYWISE DISTRIBUTION OF MOD (n=655) 
ETIOLOGY LSCS VAGINAL 
TTN(242) 145(59.91%) 97(40.09%) 
BA(144) 48(33.33%) 96(66.67%) 
MAS(93) 53(56.99%) 40(43.01%) 
CHD(78) 48(61.54%) 30(38.46%) 
SEP & PN(73) 33(45.2%) 40(54.8%) 
RDS(1) 0(0%) 1(100%) 
SURGICAL(7) 5(71.4%) 2(28.6%) 
OTHERS(17) 9(52.94%) 8(47.06%) 
TOTAL(655) 341 314 
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Out of the total 242 TTN cases 145 were delivered by LSCS and 97 were 
delivered by vaginal delivery with more cases delivered by LSCS. In Birth asphyxia 
more cases were delivered by vaginal route (96) than LSCS (48 cases). 53 cases of 
MAS were delivered by LSCS and 40 cases were delivered by vaginal route. In CHD 
48 were delivered by LSCS and 30 were delivered by vaginal route. In sepsis and 
pneumonia 33 were delivered by LSCS and 40 were delivered by vaginal route with 
more cases delivered by vaginal route .In RDS 1 case was delivered by vaginal 
delivery .In Surgical causes 5 were delivered by LSCS and 2 were delivered 
vaginally. In other causes 9 were delivered by LSCS and 8 were delivered by vaginal 
delivery. Thus TTN, MAS, CHD and other causes were common in cases delivered 
by LSCS, whereas Birth asphyxia, Sepsis, Pneumonia and RDS were common in 
cases delivered by vaginal route. 
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TABLE 16: PLACE OF DELIVERY (n=655) 
PLACE No. PERCENTAGE 
INBORN 489 74.66 
OUTBORN 166 25.34 
TOTAL 655 100 
 
Out of the 655 newborns, 489 were inborn, 166 were out born with 74.66 % 
inborn cases and 25.34% out born cases. 
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TABLE 17: NEED FOR RESUSCITATION (n=655) 
NFR No. PERCENTAGE 
YES 202 30.84 
NO 453 69.16 
TOTAL 655 100 
 
Resuscitation was required in 202 cases (30.84%) and 453 cases did not need 
resuscitation (69.16%). 
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TABLE 18: ETIOLOGY WISE DISTRIBUTION OF NFR (n=655) 
ETIOLOGY YES NO 
TTN(242) 9 233 
BA(144) 141 3 
MAS(93) 26 67 
CHD(78) 7 71 
SEP & PN(73) 17 56 
RDS(1) 0 1 
SURGICAL(7) 0 7 
OTHERS(17) 2 15 
TOTAL(655) 202 453 
 
Resuscitation was required most commonly for birth asphyxia cases(141). 9 cases 
of TTN, 26 cases of MAS, 7 cases of CHD, 17 cases of sepsis and pneumonia, 2 cases 
with other causes required resuscitative measures.  
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TABLE 19: MODE OF OXYGENATION 
MODE OF 
OXYGENATION 
NUMBER PERCENTAGE 
NASAL O2 372 56.79 
CPAP 217 33.13 
MV 66 10.08 
TOTAL 655 100 
 
Out of the 655 newborns, 372 required Oxygen supplementation by nasal oxygen, 
217 cases required CPAP and Mechanical ventilator was needed by 66 cases. 
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TABLE 20: ETIOLOGYWISE O2 REQUIREMENT 
ETIOLOGY NASAL O2 CPAP MV 
TTN(242) 220 22 0 
BA(144) 36 73 35 
MAS(93) 16 58 19 
CHD(78) 45 30 3 
SEPSIS&PN(73) 39 31 3 
RDS(1) 0 1 0 
SURGICAL(7) 5 1 1 
OTHER(17) 11 1 5 
TOTAL(655) 372 217 66 
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    Out of total 242 TTN cases 220 required nasal O2, 22 required CPAP and no cases 
required mechanical ventilation. In birth asphyxia 36 required nasal o2, 73 needed 
CPAP and 35 required mechanical ventilation. In MAS 16 cases required nasal O2, 58 
needed CPAP and 19 cases were mechanically ventilated. In CHD 45 required nasal 
O2, 30 required CPAP and 3 needed mechanical ventilators. 39 cases of sepsis and 
pneumonia required nasal O2, 25 required CPAP and 1 case was mechanically 
ventilated. In RDS 1 case required CPAP. In respiratory distress due to surgical 
causes 5 required nasal O2, 1 required CPAP and 1 required mechanical ventilation. 
In other causes 16 required nasal O2, 2 required CPAP and 6 cases required 
mechanical ventilation. Most of the TTN cases were managed with hood. CPAP is 
commonly needed for BA, MAS and pneumonia cases. Mechanical ventilation is 
commonly needed for Birth asphyxia and MAS cases. 
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TABLE 21: CHEST X RAY (n=655) 
ETIOLOGY ABNORMAL NORMAL 
TTN 37 205 
BA 11 133 
MAS 88 5 
CHD 28 50 
SEPSIS&PN 24 49 
RDS 1 0 
SURGICAL 2 5 
OTHERS 6 11 
TOTAL(655) 197 458 
 
Out of the 655 cases 197 cases had abnormal chest x ray findings. 37 cases of 
TTN, 11 cases of birth asphyxia, 88 cases of MAS, 28 cases of CHD, 24 cases of 
sepsis and pneumonia , 1 RDS case, 2 cases due to surgical causes and 6 cases due to 
other respiratory causes had abnormal chest x ray findings. Most of the cases of MAS 
and Pneumonia had findings in radiograph. 
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TABLE 22: DAYS OF HOSPITALISATION (n=655) 
DAYS OF HOSP. No. PERCENTAGE 
≤3 DAYS 213 32.52 
>3   DAYS 442 67.48 
TOTAL 655 100 
       
Out of the 655 newborns 213(32.52%) were either discharged or died within 3 
days and 442 cases were either discharged or died after 3 days. 
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TABLE 23: DAYS OF HOSPITALISATION (n=655) 
ETIOLOGY ≤3 DAYS >3   DAYS 
TTN(242) 134 108 
BA(144) 30 114 
MAS(93) 22 71 
CHD(78) 18 60 
SEP & PN(73) 2 71 
RDS(1) 0 1 
SURGICAL(7) 2 5 
OTHERS(17) 5 12 
TOTAL(655) 213 442 
 
Out of the 242 TTN cases admitted during the study duration of stay was ≤ 3days 
in 134 cases and > 3days in 108 cases, 30 cases of Birth asphyxia stayed for ≤3 days, 
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whereas 114 cases stayed for>3 days. In MAS, duration of stay was ≤ 3 days in 22 
cases and >3 days in 71 cases. 
In CHD duration of stay was ≤ 3 days in 18 cases and > 3 days in 60 cases. In 
sepsis and pneumonia duration of stay was ≤3 days in 2 cases and > 3 days in 71 
cases. In RDS duration of stay was > 3 days in 1 case. 2 cases of surgical causes and 5 
cases of distress due to other causes stayed for ≤ 3 days and 5 cases of surgical causes 
and 12 cases due to other causes stayed for > 3 days. Duration of stay was ≤ 3 days in 
most of the TTN cases whereas duration of stay > 3 days  was mostly due to Birth 
asphyxia cases and MAS cases. 
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TABLE 24: MATERNAL AGE (n=655) 
MATERNAL AGE NUMBER PERECENTAGE 
≤18 or ≥35 63 9.62 
19-34 592 90.38 
TOTAL 655 100 
 
Maternal age was ≤ 18 or ≥ 35 in 63 cases and 19 – 34 in 592 cases, 9.62 % of 
mothers were in extreme age group 
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TABLE 25: PARITY: (n=655) 
PARITY NUMBER PERCENTAGE 
PRIMI 328 50.08 
2-4 286 43.66 
>4 41 6.26 
TOTAL 655 100 
 
Out of the 655 newborns with respiratory distress, 328 were born to primi 
mothers, 286 newborns were born to G 2 to G4 mothers and 41 newborns were born 
to grand multipara mothers (G>4). 
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TABLE 26: MATERNAL ILLNESS (n=655) 
MATERNAL ILLNESS NUMBER PERCENTAGE 
YES 197 30.08 
NO 458 69.92 
TOTAL 655 100 
 
Maternal illness like GDM, PIH , Anemia were present in 197 mothers(30.08%) of 
babies with respiratory distress and absent in 458 mothers of babies with respiratory 
distress(69.92%). 
  
 
NO
458
70%
YES
197
30%
Fig.26 : MATERNAL ILLNESS
NO
YES
70 
 
TABLE 27: PROLONGED LABOUR (n=655) 
PROLONGED LABOUR NUMBER PERCENTAGE 
YES 107 16.34 
NO 548 83.66 
TOTAL 655 100 
 
     Out of 655 newborns admitted for respiratory distress, Prolonged labour was 
present in 107 deliveries (16.34%) and absent in 548 deliveries (83.66%). 
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TABLE 28: PROLONGED RUPTURE OF MEMBRANES (n=655) 
PROM NUMBER PERCENTAGE 
YES 89 13.59 
NO 566 86.41 
TOTAL 655 100 
 
Out of 655 newborns admitted for respiratory distress, Prolonged rupture of 
membranes was present in 89 deliveries (13.59%) and absent in 566 deliveries 
(86.41%) . 
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TABLE 29: MECONIUM STAINED AMNIOTIC FLUID 
MSAF NUMBER PERCENTAGE 
YES 150 22.90 
NO 505 77.10 
TOTAL 655 100 
 
   Out of 655 newborns admitted for respiratory distress, Meconium stained amniotic 
fluid was present in 150 deliveries (22.9%) and absent in 505 deliveries (77.10%). 
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DISCUSSION 
Respiratory distress is a major contributor to newborn admission in NICU. It also 
contributes to significant morbidity and mortality. Respiratory distress is not a disease 
per se, but a common manifestation of varying disorders of both respiratory and non 
respiratory etiology. These disorders may have onset immediately following birth or 
few hours after birth depending on the underlying condition and gestational age of the 
baby. Various factors both antenatal and postnatal influence the occurrence of 
distress. Many such conditions have overlapping clinical manifestations and 
radiological findings making the diagnosis of each condition difficult. Since it is a 
major cause of neonatal morbidity and mortality, knowledge about its cause is 
essential in planning the guidelines for management. Any attempt to decrease the 
incidence and mortality associated with the condition needs understanding of the 
varying causes leading to the occurrence of respiratory distress. Many maternal co 
morbid conditions, factors related to delivery and neonatal factors like gestational age 
and birth weight influence the incidence of distress. Varying studies have been 
conducted in different parts of the world and across our nation to find the incidence of 
conditions leading to respiratory distress in newborn period. Many such studies 
include the preterm babies also where the major cause of distress is Respiratory 
distress syndrome. Studies finding the etiological profile of respiratory distress in 
term babies are less, that too in South India are even more less. In this situation this 
study is planned to study the clinical profile of respiratory distress in term infants in 
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the early neonatal period and evaluate its immediate outcome. The maternal factors, 
factors related to delivery and neonatal factors associated with the condition are also 
studied. Therapeutic interventions influencing the outcome are also studied. Thus this 
study will help in identifying the causes of respiratory distress in the early neonatal 
period and the factors influencing its outcome, henceforth help in planning measures 
to decrease the morbidity and mortality associated with respiratory distress. 
During the study period a total of 2152 newborns were admitted in our SNN , of 
which a total of 655 term  newborns  were admitted with  onset of  respiratory distress 
in early neonatal period . These 655 babies were included in the study and the clinical 
profile of respiratory distress and its immediate outcome are analysed. 
NEONATAL CHARACTERISTICS: 
TABLE 30: INCIDENCE OF RESPIRATORY DISTRESS 
STUDY  INCIDENCE 
Haquea et al(3) 34% 
Sirageldin MK Abderlrahman et al(4) 56.5% 
Assel Mohammed Wadi et al(8) 50 % 
Santhosh et al(6) 13.7% 
Keerti Swarnakar et al(7) 16.3% 
Present Study 30.43% 
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The incidence in our study is similar to other studies. 
TABLE 31: ETIOLOGY OF RESPIRATORY DISTRESS 
STUDY 
TTN 
% 
BA 
% 
MAS 
% 
SEP      
+ 
PN % 
CHD 
% 
RDS 
% 
Others 
% 
Haquea et al(3)  43.2 25 1.5   28 10.4 30.2 2 
SirageldinMK 
Abderlrahman et al(4) 
28  6   24    9 15 18 
Assel Mohammed  
Wadi et al(5) 
44.9 13.2 9.6 16.2 7.8 1.2 7.2 
Santhosh et al(6) 46 25 7.8 25 1.3 31.5 3.9 
Keerti Swarnakar et 
al(7) 
40.7 11.4 9.3 7.9 3.5 17.1 10 
Abhijit et al(8) 32.3 12.5 13.15 24.3 3.3 7.9 3.94 
Present study 36.95 21.98 14.2 11.14 11.91 0.16 3.66 
 
In our study also TTN is the most common cause of respiratory distress which is 
comparable to previous studies, Birth asphyxia is the second most common cause of 
respiratory distress which is also similar to previous studies.MAS followed by CHD 
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are the other common causes for respiratory distress in our study which is comparable 
to previous studies. Sepsis and Pneumonia as a cause of Respiratory distress is less 
when compared to previous studies. Other causes constitute a minor cause of 
respiratory distress as in other studies. 
TABLE 32: DISTRIBUTION OF OUTCOME  
STUDY DEATH% DISCHARGE% 
Haquea et al(3) 16.7 83.3 
SirageldinMKAbderlrahman et al(4) 36 64 
Assel Mohammed Wadi et al(5) 9 91 
Santhosh et al(6) 7.8 92.2 
Keerti Swarnakar et al(7) 22.86 77.14 
Present study 9.01 90.99 
 
In our study mortality rate is 9.01% which is comparable to previous studies. 
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TABLE 33: CASE FATALITY RATE 
STUDY TTN BA MAS CHD 
SEP 
& 
PN 
RDS Others 
SirageldinMKAbderlra
hman et al  (4) 
0  33.3 55.6 33.3 86.7 44.44 
AsselMohammedWadi 
etal(5) 
0 33.33 0 13.33 33.33 0 13.33 
Keerti Swarnakar et 
al(7) 
0 31.25 30.8 60 36.4 33.3 14.3 
Present study 0 20.83 18.28 5.13 23.78 0 20.83 
 
In our study CFR for TTN is similar to previous studies, CFR for BA is 
comparable to previous studies, CFR for MAS is less than the previous studies, CFR 
for CHD is much less than the previous studies, CFR for sepsis and pneumonia is 
comparable to previous studies, CFR for other causes is comparable to previous 
studies. 
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TABLE 34: GENDER DISTRIBUTION OF NEONATES 
STUDY MALE% FEMALE% 
Haquea et al(3) 64 36 
Sirageldin MK Abderlrahman et al(4) 54 46 
Assel Mohammed Wadi et al(5) 61.68 38.32 
Present study 63.53 36.47 
 
In our study results are similar to other studies. 
 
TABLE 35: PLACE OF DELIVERY 
STUDY  INBORN% OUTBORN% 
Haquea et al(3) 66.67 33.33 
Present study 74.66 25.34 
 
 In this study also it is comparable to the previous study. 
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TABLE 36: MODE OF DELIVERY 
STUDY LSCS% VAGINAL% 
Haquea et al(3) 84 16 
Assel Mohammed Wadi et al(5) 50.3 49.7 
Keerti Swarnakar et al(7) 67.6 32.4 
Present study 52.06 47.94 
 
In our study cases delivered by LSCS is more than the cases delivered by vaginal       
delivery and is similar to previous studies. 
 
TABLE 37: NEED FOR RESUSCITATION 
STUDY YES% NO% 
Assel Mohammed Wadi et al(5) 24.6 75.4 
Present study 30.84 69.16 
  
In this study also results are similar to previous studies 
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TABLE 38: CHEST X RAY FINDINGS 
STUDY ABNORMAL NORMAL 
Temesgen Tadasse et al  44 66 
Santhosh et al(6) 75 25 
Present study 69.9 30.1 
 
In this study abnormal chest x ray findings are comparable to previous studies. 
 
TABLE 39: NEED FOR MECHANICAL VENTILATION 
STUDY YES% NO% 
Haquea et al(3) 25 75 
Santhosh et al(6) 21 79 
Present study 9.93 91.07 
 
In our study requirement for mechanical ventilation is less than the previous studies. 
TABLE 40: NEED FOR CPAP  
STUDY YES% NO% 
Haquea et al(3) 4.1 95.9 
Present study 33.13 66.87 
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In our study CPAP was needed for more babies. 
TABLE 41: DAYS OF HOSPITALIZATION 
   STUDY <3 days % ≥3days % 
 Assel Mohammed Wadi et al(5) 45.5 54.5 
 Present study 32.52 67.48 
 
In this study more babies required hospital stay of > 3 days compared to the 
previous study. 
 
MATERNAL AND LABOUR CHARACTERISTICS: 
TABLE 42: MATERNAL ILLNESS 
STUDY YES % NO % 
Assel Mohammed Wadi et al(5) 19.2 80.8 
Keerti Swarnakar et al(7) 12.14 87.86 
Present study 30.08 69.92 
 
In our study maternal illness is present in more mothers than the previous studies. 
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TABLE 43: MATERNAL AGE 
 STUDY ≤18yr  &  ≥35 yrs % 19-34 yrs % 
Assel Mohammed Wadi et al(5) 23.4 76.6 
Temesgen Tadasse et al 11 89 
Present study 9.62 90.38 
 
In our study, result is similar to previous studies. 
      
    TABLE 44: PARITY 
  STUDY PRIMI & >4 (%) 2 to 4 (%) 
Assel Mohammed Wadi et al(5) 41.9 58.1 
Temesgen Tadasse et al 56 44 
Present study 56.34 43.66 
 
In our study, results are comparable to previous studies. 
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      TABLE 45: PROLONGED RUPTURE OF MEMBRANES 
STUDY YES % NO % 
    Assel Mohammed Wadi et al(5) 11.4 88.6 
    Keerti Swarnakar et al(7) 12.14 87.86 
    Present study 13.59 86.41 
 
In our study, results are similar to previous studies. 
 
TABLE 46: MECONIUM STAINED AMNIOTIC FLUID 
STUDY YES% NO% 
   Assel Mohammed Wadi et al(5) 19.8 80.2 
   Keerti Swarnakar et al(7) 11.43 88.57 
   Present study 22.90 77.10 
 
In our study also results are comparable to previous studies. 
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CONCLUSION 
  Respiratory distress is a common cause of newborn admission in NICU. TTN is 
the most common cause of respiratory distress in term newborns, followed by 
Perinatal asphyxia, Meconium aspiration and Congenital heart diseases. Sepsis and 
pneumonia varies in different centres. A small proportion of respiratory distress is due 
to other causes like congenital diaphragmatic hernia, anemia, congenital lobar 
emphysema, congenital anomalies etc. 
Though TTN is the most common cause of distress, it is usually self limited and 
carries good prognosis. The main causes for death are Perinatal asphyxia, MAS, 
Sepsis and Pneumonia. Hence, any measure to reduce the morbidity and mortality 
associated with respiratory distress should be aimed at effective management of these 
conditions. 
Incidence of respiratory distress is more in males compared to females.  
Incidence is more in cases delivered by caesarean section than those delivered by 
vaginal delivery. Hence, judicious indications should be available for caesarean 
deliveries. 
Incidence is more in babies delivered at early term (37-38wks) than those 
delivered at late term (39-40wks). Thus elective caesarean sections should be planned 
after the completion of early term gestation. 
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A significant proportion of babies require resuscitative measures. Hence, adequate 
skill in effective resuscitation is a must for appropriate management of these babies. 
Chest Radiographic findings are abnormal only in one third of babies, hence 
undue importance to imaging should be avoided and high index of clinical suspicion 
is essential. 
Use of Continuous positive airway pressure decreases the need for mechanical 
ventilation in babies with respiratory distress. 
The occurrence of respiratory distress is more in mothers with underlying illness, 
hence early identification of maternal illness and its effective management is essential 
to decrease the incidence of respiratory distress. 
Primi and grand multipara mothers are at more risk of delivering babies with 
respiratory distress. 
Mothers ≤18 yrs and ≥35 yrs have increased chance of delivering babies with 
respiratory distress. 
Presence of labour complications like prolonged rupture of membranes and 
Meconium stained amniotic fluid increase the incidence of respiratory distress. Hence 
timely management of these conditions is needed. 
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LIMITATIONS 
Long term complications and outcome was not followed up since it does not come 
under the purview of the study. 
FUTURE IMPLICATIONS 
Perinatal asphyxia and MAS are the main reasons for death due to respiratory 
distress. Therefore improvement in antenatal management of labour by early referral 
of high risk mothers to tertiary care centres will reduce the need for resuscitation and 
decrease the morbidity and mortality associated with respiratory distress. As early 
term neonates are at increased risk for developing respiratory distress, elective 
caesarean sections should be planned in the late term period. Early recognition of 
maternal infection and starting empirical antibiotic therapy, following aseptic 
precautions during delivery will decrease the incidence of early onset pneumonia and 
sepsis. As maternal illness like GDM , Anemia , PIH etc are associated with neonatal 
respiratory distress, early identification of these conditions in the antenatal period and 
appropriate management are essential. 
Training of staff in resuscitative measures is useful to decrease the morbidity 
associated with respiratory distress. 
Assessing the severity of distress by scoring, helps in guiding therapy. Use of 
CPAP for moderate to severe distress decreases the need for mechanical ventilation, 
thereby reduces the duration of stay and mortality. 
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Future interventional studies assessing the effectiveness of various interventions 
will help us in planning cost effective measures that can be implemented in peripheral 
centres to reduce the morbidity and mortality of respiratory distress. 
 
 
BIBLIOGRAPHY 
1.  Neonatal morbidity and mortality: report of the National Neonatal-Perinatal 
Database. Indian Pediatr. 1997 Nov;34(11):1039–42.  
2.  Kumar A, Bhat BV. Epidemiology of respiratory distress of newborns. Indian J 
Pediatr. 1996 Feb;63(1):93–8.  
3.  Haque A, Baki MA, Begum T, Akhter S, Begum S, Nahar N. Etiology of 
Respiratory Distress in Newborn – Experience in BIRDEM. BIRDEM Med J. 2013 
Nov 24;3(1):19–22.  
4.  Abdelrahman SM, Hamed SM, Nasr A. Neonatal respiratory distress in Omdurman 
Maternity Hospital, Sudan. Sudan J Paediatr. 2014;14(1):65–70.  
5.  Wadi1 AM. Respiratory Distress in Full Term Neonates in the First Week of Life in 
Basrah Maternity and Children Hospital. Med J Basrah Univ. 2012;30(2):91–8.  
6.  Santosh S, Kushal kumar K, Adarsha E. A Clinical study of Respiratory Distress In 
Newborn and its Outcome. Indian Journal of Neonatal Medicine and Research. 2013 
April; 1:2-4.  
7.  Swarnkar K, Swarnkar M. Neonatal respiratory distress in early neonatal period and 
its outcome. Int J Biomed Adv Res. 2015 Sep 8;6(9):643–7.  
8.  Dutta A. Spectrum of Respiratory Distress in Newborn: A Study from a Tertiary 
Care Hospital in Kolkata. 2011 Apr 30;15(2).  
9.  Bajad M, Goyal S, Jain B. Clinical profile of neonates with respiratory distress. Int J 
Contemp Pediatr. 2016;1009–13.  
10.  Zaazou MH, Kamal MM, Ali RM, EL-Hussieny NA, EL-Sayed M. Descriptive 
study of cases of respiratory distress in NICU in Ahmed Maher Teaching hospital. 
The Medical Journal of Cairo University. 2011;79(2).  
11.  Sahoo M, Vasundhara A, Rao M, Alekhya J, Nagasree P. Clinicoetiological profile 
and risk assessment of newborn with respiratory distress in a tertiary care centre in 
South India. Int J Contemp Pediatr. 2015;433–9.  
12.  Edwards MO, Kotecha SJ, Kotecha S. Respiratory distress of the term newborn 
infant. Paediatr Respir Rev. 2013 Mar;14(1):29-36-37.  
13.  Kim H-A, Yang G-E, Kim M-J. Early Neonatal Respiratory Morbidities in Term 
Neonates. Neonatal Med. 2015;22(1):8.  
14.  Kasap B, Duman N, Ozer E, Tatli M, Kumral A, Ozkan H. Transient tachypnea of 
the newborn: predictive factor for prolonged tachypnea. Pediatr Int Off J Jpn Pediatr 
Soc. 2008 Feb;50(1):81–4.  
15.  Ersch J, Roth-Kleiner M, Baeckert P, Bucher HU. Increasing incidence of 
respiratory distress in neonates. Acta Paediatr Oslo Nor 1992. 2007 
Nov;96(11):1577–81.  
16.  Tochie JN, Choukem S-P, Langmia RN, Barla E, Koki-Ndombo P. Neonatal 
respiratory distress in a reference neonatal unit in Cameroon: an analysis of 
prevalence, predictors, etiologies and outcomes. Pan Afr Med J. 2016;24:152.  
17.  Chandrasekhar R, Mohan M, Lakshmi B. Clinical study of respiratory distress in 
newborn. Int J Contemp Pediatr. 2016;910–5.  
18.  Avery ME, Gatewood OB, Brumley G. Transient tachypnea of newborn. Possible 
delayed resorption of fluid at birth. Am J Dis Child 1960. 1966 Apr;111(4):380–5.  
19.  Dani C, Reali MF, Bertini G, Wiechmann L, Spagnolo A, Tangucci M, et al. Risk 
factors for the development of respiratory distress syndrome and transient 
tachypnoea in newborn infants. Italian Group of Neonatal Pneumology. Eur Respir 
J. 1999 Jul;14(1):155–9.  
20.  Halliday HL, McClure G, Reid MM. Transient tachypnoea of the newborn: two 
distinct clinical entities? Arch Dis Child. 1981 May;56(5):322–5.  
21.  Lewis V, Whitelaw A. Furosemide for transient tachypnea of the newborn. 
Cochrane Database Syst Rev. 2002;(1):CD003064.  
22.  Golubnitschaja O, Yeghiazaryan K, Cebioglu M, Morelli M, Herrera-Marschitz M. 
Birth asphyxia as the major complication in newborns: moving towards improved 
individual outcomes by prediction, targeted prevention and tailored medical care. 
EPMA J. 2011 Jun;2(2):197–210.  
23.  Allen KA, Brandon DH. Hypoxic Ischemic Encephalopathy: Pathophysiology and 
Experimental Treatments. Newborn Infant Nurs Rev NAINR. 2011 Sep 
1;11(3):125–33.  
24.  Chao CP, Zaleski CG, Patton AC. Neonatal Hypoxic-Ischemic Encephalopathy: 
Multimodality Imaging Findings. RadioGraphics. 2006 Oct 1;26(suppl_1):S159–72.  
25.  Laerhoven H van, Haan TR de, Offringa M, Post B, Lee JH van der. Prognostic 
Tests in Term Neonates With Hypoxic-Ischemic Encephalopathy: A Systematic 
Review. Pediatrics. 2013 Jan 1;131(1):88–98.  
26.  Cotten CM, Shankaran S. Hypothermia for hypoxic-ischemic encephalopathy. 
Expert Rev Obstet Gynecol. 2010 Mar 1;5(2):227–39.  
27.  Manning FA, Martin CB, Murata Y, Miyaki K, Danzler G. Breathing movements 
before death in the primate fetus (Macaca mulatta). Am J Obstet Gynecol. 1979 Sep 
1;135(1):71–6.  
28.  Cleary GM, Wiswell TE. Meconium-stained amniotic fluid and the meconium 
aspiration syndrome. An update. Pediatr Clin North Am. 1998 Jun;45(3):511–29.  
29.  Zagariya A, Bhat R, Uhal B, Navale S, Freidine M, Vidyasagar D. Cell death and 
lung cell histology in meconium aspirated newborn rabbit lung. Eur J Pediatr. 
159(11):819–26.  
30.  Dargaville PA. Respiratory Support in Meconium Aspiration Syndrome: A Practical 
Guide. Int J Pediatr. 2012;2012:1–9.  
31.  Findlay RD, Taeusch HW, Walther FJ. Surfactant replacement therapy for 
meconium aspiration syndrome. Pediatrics. 1996 Jan;97(1):48–52.     
32.  Skinner JR, Hunter S, Hey EN. Haemodynamic features at presentation in persistent 
pulmonary hypertension of the newborn and outcome. Arch Dis Child Fetal 
Neonatal Ed. 1996 Jan;74(1):F26–32.   
33.  Van Marter LJ, Hernandez-Diaz S, Werler MM, Louik C, Mitchell AA. 
Nonsteroidal Antiinflammatory Drugs in Late Pregnancy and Persistent Pulmonary 
Hypertension of the Newborn. Pediatrics. 2013 Jan;131(1):79–87.   
34.  Vosatka RJ, Kashyap S, Trifiletti RR. Arginine deficiency accompanies persistent 
pulmonary hypertension of the newborn. Biol Neonate. 1994;66(2–3):65–70.   
35.  Kinsella JP, Truog WE, Walsh WF, Goldberg RN, Bancalari E, Mayock DE, et al. 
Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory 
ventilation in severe, persistent pulmonary hypertension of the newborn. J Pediatr. 
1997 Jul;131(1 Pt 1):55–62.  
36.  Davidson D, Barefield ES, Kattwinkel J, Dudell G, Damask M, Straube R, et al. 
Safety of Withdrawing Inhaled Nitric Oxide Therapy in Persistent Pulmonary 
Hypertension of the Newborn. Pediatrics. 1999 Aug 1;104(2):231–6.  
37.  McConnell ME, Elixson EM. The neonate with suspected congenital heart disease. 
Crit Care Nurs Q. 2002 Nov;25(3):17–25.  
38.  Steinhorn RH. Evaluation and management of the cyanotic neonate. Clin Pediatr 
Emerg Med. 2008 Sep;9(3):169–75.  
39.  Yun SW. Congenital heart disease in the newborn requiring early intervention. 
Korean J Pediatr. 2011 May;54(5):183–91.  
40.  Hornik CP, Fort P, Clark RH, Watt K, Benjamin DK, Smith PB, et al. Early and late 
onset sepsis in very-low-birth-weight infants from a large group of neonatal 
intensive care units. Early Hum Dev. 2012 May;88 Suppl 2:S69-74.  
41.  Simonsen KA, Anderson-Berry AL, Delair SF, Davies HD. Early-Onset Neonatal 
Sepsis. Clin Microbiol Rev. 2014 Jan 1;27(1):21–47.  
42.  Schuchat A. Neonatal Group B Streptococcal Disease — Screening and Prevention. 
N Engl J Med. 2000 Jul 20;343(3):209–10.  
43.  Nissen MD. Congenital and neonatal pneumonia. Paediatr Respir Rev. 2007 
Sep;8(3):195–203.  
44.  Webber S, Wilkinson AR, Lindsell D, Hope PL, Dobson SR, Isaacs D. Neonatal 
pneumonia. Arch Dis Child. 1990 Feb;65(2):207–11.  
45.  Duke T. Neonatal pneumonia in developing countries. Arch Dis Child Fetal 
Neonatal Ed. 2005 May;90(3):F211–9.  
46.  Lazzerini M, Sonego M, Pellegrin MC. Hypoxaemia as a Mortality Risk Factor in 
Acute Lower Respiratory Infections in Children in Low and Middle-Income 
Countries: Systematic Review and Meta-Analysis. PLOS ONE. 2015 Sep 
15;10(9):e0136166.  
47.  Nogee LM, Garnier G, Dietz HC, Singer L, Murphy AM, deMello DE, et al. A 
mutation in the surfactant protein B gene responsible for fatal neonatal respiratory 
disease in multiple kindreds. J Clin Invest. 1994 Apr;93(4):1860–3.  
48.  Kavvadia V, Greenough A, Dimitriou G, Forsling M. Comparison of respiratory 
function and fluid balance in very low birthweight infants given artificial or natural 
surfactant or no surfactant treatment. J Perinat Med - Off J WAPM. 
2009;26(6):469–474.  
49.  Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung 
maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 
2006;(3):CD004454.  
50.  Wenstrom KD, Weiner CP, Hanson JW. A five-year statewide experience with 
congenital diaphragmatic hernia. Am J Obstet Gynecol. 1991 Oct;165(4):838–42.  
51.  Lally KP, Paranka MS, Roden J, Georgeson KE, Wilson JM, Lillehei CW, et al. 
Congenital diaphragmatic hernia. Stabilization and repair on ECMO. Ann Surg. 
1992 Nov;216(5):569–73.  
52.  Jeng M-J, Lee Y-S, Tsao P-C, Soong W-J. Neonatal air leak syndrome and the role 
of high-frequency ventilation in its prevention. J Chin Med Assoc JCMA. 2012 
Nov;75(11):551–9.  
53.  Lago P, Benini F, Agosto C, Zacchello F. Randomised controlled trial of low dose 
fentanyl infusion in preterm infants with hyaline membrane disease. Arch Dis Child 
- Fetal Neonatal Ed. 1998 Nov 1;79(3):F194–7.  
 
 
  
PROFORMA 
 
NAME :   Baby of…………….                              IP NO    : 
SEX     :                                                           MOTHER’S IP NO  : 
DOB    :                                   DOA   : 
NEONATE DETAILS: 
Gestational Age     :  
(Completed weeks) 
Birth Weight     : 
Need for Resuscitation    : 
Age at Admission (in hours)   : 
MATERNAL  DETAILS: 
Age (years)     : 
Parity (G_ P_)     : 
Any Comorbid Illness    : 
DELIVERY DETAILS: 
Prolonged rupture of membrane             : (Yes or No) 
Prolonged labour                      : (Yes or No) 
Meconium staining of liquor   : (Yes or No) 
Type of delivery                                     : (LN/LSCS/ASSISTED) 
Place of delivery                                        :Inborn/outborn (PHC/GH/Pvt.) 
    
CLINICAL FINDINGS: 
 
General 
examination 
 
 
Vitals 
 
 
CVS 
 
 
P/A 
 
 
CNS 
 
 
Sp02 
 
      
 
Respiratory 
Rate 
Retractions Cyanosis Grunting 
Air 
Entry 
Downe’ 
score 
      
 
INVESTIGATIONS 
CXR NEC CRP ECHO OTHERS 
Normal   Abn 
    
  
 
FINAL DIAGNOSIS: (Tick) 
TTN  Sepsis  
RDS  Anemia  
MAS  CHD  
Birth Asphyxia  Pneumothorax  
Pneumonia  Others  
 
 
FOLLOW UP 
Mode Of Oxygenation   : Hood/CPAP/Ventilator 
Days of Hospitalisation   : 
Final  Outcome                                    : Discharge/Death 
 
 
KEY TO MASTER CHART 
 
ABN-Abnormal 
APH-Antepartum Hemorrhage 
ASD-Atrial Septal Defect 
ASH-Asymmetric Septal Hypertrophy 
B/O-Baby Of 
BA-Birth Asphyxia 
CA-Choanal Atresia 
CCHD-Cyanotic Congenital Heart Disease 
CDH-Congenital diaphragmatic hernia 
CHD-Congenital heart disease 
CL&CP-Cleft lip & Cleft palate 
CLE-Congenital lobar emphysema 
CM-Congenital malformation 
COM.ILL-Comorbid illness 
CPAP-Continuous Positive Airway Pressure 
CRP-C reactive protein 
CXR-Chest x ray 
DIAG-Diagnosis 
DOWNE-Downe’s score 
FCH-Female child 
GA-Gestational Age 
GDM-Gestational Diabetes Mellitus 
HYPOTY-Hypothyroidism 
I-Inborn 
LM-Laryngomalacia 
LN-Labour Natural 
LSCS-Lower segment caesarean section 
MAS-Meconium aspiration syndrome 
MAT.AGE-Maternal age 
MCH-Male child 
MM-Meningomyelocele 
MOO-Mode of oxygenation 
MSAF-Meconium stained amniotic fluid 
MV-Mechanical ventilation 
N-Normal 
NEC-Non enteric culture 
NFR-Need for resuscitation 
O-Others 
OF-Outlet forceps 
OI-Osteogenesis imperfecta 
PDA-Patent ductus arteriosus 
PFO-Patent foramen ovale 
PHT-Pulmonary hypertension 
PIH-Pregnancy induced hypertension 
PN-Pneumonia 
POS-Positive 
PPHN-Persistent pulmonary hypertension of newborn 
PRLB-Prolonged labour 
PROM-Prolonged rupture of membranes 
RDS-Respiratory distress syndrome 
TAPVC-Total anomalous pulmonary venous connection 
TGA-Transposition of great arteries 
TOF-Tetralogy of fallot 
TR-Tricuspid regurgitation 
TTN-Transient tachypnea of newborn 
UAA-Upper airway anomaly 
UTI-Urinary tract infection 
VSD-Ventricular septal defect 
 
S.NO NAME(B/O) IP.NO SEX GA WT NFR MAT.AGE PARITY COM.ILL PROM PRLB MSAF DELIVERY PLACE DOWNE CXR NEC CRP ECHO DIAG MOO STAY OUTCOME
1 VANATHI 4382 MCH 39 2.7 NO 20 G3P1L1A1 NO NO NO NO LSCS I 2 N N N N TTN HOOD 4 DISCHARGE
2 SUMATHI 4400 FCH 40 2.25 NO 22 G1 NO NO NO YES LSCS I 5 ABN N N N MAS CPAP 7 DISCHARGE
3 SUGANTHI 4505 MCH 38 2.77 YES 25 G2P1L1 NO NO NO NO LN O 4 N N N N BA CPAP 4 DISCHARGE
4 GEETHA 4557 MCH 39 2.55 NO 25 G2P1L1 CHD NO NO NO LN I 2 N N N N TTN HOOD 6 DISCHARGE
5 NAGAJOTHI 4596 MCH 38 2.98 NO 23 G2P1L1 NO NO YES NO LSCS I 3 N N N N TTN HOOD 5 DISCHARGE
6 KRISHNAVENI 4680 FCH 39 3.28 NO 27 G4P3L2 ANEMIA NO NO NO LN I 6 ABN N N N O-CDH MV <1 DEATH
7 NATHIYA 4772 MCH 38 2.26 NO 24 G2P1L1 GDM NO NO NO LSCS I 3 N N N N TTN HOOD 5 DISCHARGE
8 SELVI 4785 MCH 39 2.75 NO 27 G2A1 HYPOTY NO NO NO LSCS I 3 N N N N TTN HOOD 4 DISCHARGE
9 RAJALAKSHMI 5048 MCH 40 3.12 NO 25 G1 ANEMIA NO NO YES LN O 4 ABN N N N MAS CPAP 4 DISCHARGE
10 NAGAJOTHI 5203 FCH 40 2.95 YES 18 G2A1 ANEMIA NO NO YES LN O 4 N N N N BA CPAP 7 DISCHARGE
11 VEERACHINNU 5265 FCH 37 2.39 NO 35 G1 NO NO NO NO LSCS I 3 N N N N TTN HOOD 4 DISCHARGE
12 AKILA 5327 MCH 38 3.12 NO 27 G1 NO YES YES NO LSCS I 3 N POS POS N SEPSIS HOOD 12 DISCHARGE
13 JAYAPRIYA 5358 FCH 37 2.32 YES 21 G3P1L1A1 ANEMIA NO NO NO LSCS O 4 N N N N BA CPAP 7 DISCHARGE
14 RAJESWARI 5448 MCH 39 3.12 NO 27 G3P1L1A1 NO YES YES YES LSCS I 6 ABN N N N MAS CPAP 7 DISCHARGE
15 VANITHA 5508 FCH 40 3.37 NO 23 G3P1L1A1 NO NO NO NO LSCS I 3 ABN N N N TTN HOOD 3 DISCHARGE
16 JOTHIMANI 5516 FCH 40 3.38 YES 20 G2A1 NO YES YES NO LN I 6 N N N N BA CPAP 11 DISCHARGE
17 NAGAJOTHI 5702 FCH 38 3.36 YES 19 G1 NO NO YES YES OF I 5 ABN N N N BA MV 13 DISCHARGE
18 INDHUMATHI 5788 MCH 39 3.82 NO 25 G4P1L1A2 NO NO NO NO LN O 6 ABN N N PDA CHD CPAP 7 DISCHARGE
19 SUMITHA 5667 FCH 38 2.75 NO 19 G2P1L1 NO NO NO YES LN O 4 ABN N N N MAS CPAP 6 DISCHARGE
20 TAMILMANI 5871 MCH 39 3.52 NO 27 G1 NO NO NO NO LN I 3 N N N N O-UAA HOOD 7 DISCHARGE
21 RAMBHA 6006 FCH 37 3.12 NO 19 G1 NO NO NO YES LSCS O 5 ABN N N PDA MAS CPAP 13 DISCHARGE
22 JEYAKODI 6170 MCH 38 2.31 NO 23 G2A1 NO NO NO NO LN O 3 ABN N N N TTN HOOD 1 DISCHARGE
23 SUGANYA 6257 FCH 37 2.53 NO 20 G1 NO YES YES NO LN I 3 ABN N N N TTN HOOD 7 DISCHARGE
24 SANGUTHAI 6304 MCH 38 3.32 YES 27 G1 NO NO NO NO LN O 6 N N N N BA CPAP 8 DISCHARGE
25 SHANMUGAPRIYA 6580 MCH 40 4.4 NO 30 G1 NO NO NO NO LSCS I 3 N N N N TTN HOOD 3 DISCHARGE
26 MANIMEGALAI 6715 FCH 38 2.75 NO 22 G2P1L1 NO NO NO NO LN O 3 N N N N O-LM HOOD 7 DISCHARGE
27 PUSHPAM 6884 MCH 39 2.95 NO 24 G2P1L1 NO NO NO NO LSCS I 3 ABN N N N TTN HOOD 4 DISCHARGE
28 DURGADEVI 6668 MCH 40 3.5 NO 31 G1 NO NO NO NO LSCS I 5 ABN N N ASD CHD CPAP 6 DISCHARGE
29 SIVABALA 7099 MCH 38 3.4 NO 21 G1 NO NO NO NO OF I 3 N N N N TTN HOOD 2 DISCHARGE
30 ARIVUSELVI 7091 FCH 40 3.6 NO 25 G1 PIH NO NO NO LSCS I 5 ABN N N N MAS CPAP 7 DISCHARGE
31 PETCHIAMMAL 7269 FCH 38 2.8 NO 25 G2P1L1 NO NO NO NO LSCS I 3 ABN N N N MAS HOOD 3 DISCHARGE
32 POOMINA 7369 FCH 38 3.06 YES 21 G1 NO YES YES NO OF I 6 N N N N BA CPAP 7 DISCHARGE
33 KALLESWARI 7422 FCH 37 2.17 NO 20 G1 NO NO NO NO LN O 3 ABN POS POS N SEPSIS HOOD 13 DISCHARGE
34 KALAISELVI 7607 MCH 39 3.63 YES 26 G3P2L2A1 NO NO YES NO LSCS O 3 ABN N N ASD CHD HOOD 7 DISCHARGE
35 SARITHA 7668 MCH 38 2.7 YES 21 G1 NO NO NO YES LSCS I 6 ABN N N N MAS CPAP 7 DISCHARGE
36 SUMATHI 7877 MCH 39 3.8 NO 30 G5P1L1A3 GDM NO NO NO LSCS I 3 N N N N TTN HOOD 7 DISCHARGE
37 RADHA 7917 MCH 38 2.93 NO 27 G2A1 UTI NO YES NO OF I 3 ABN N N PDA CHD HOOD 6 DISCHARGE
38 SARANYA 7965 MCH 38 3.15 NO 23 G1 NO YES YES NO LSCS I 3 N POS N N SEPSIS HOOD 8 DISCHARGE
39 MYTHILI 8009 MCH 38 2.6 NO 27 G1 GDM NO NO NO LSCS I 3 ABN N N N TTN HOOD 4 DISCHARGE
40 BAPITHA 7987 MCH 38 3.87 NO 24 G1 NO NO NO NO LSCS I 3 N N N N TTN HOOD 4 DISCHARGE
41 RAJESWARI 8077 MCH 40 3.05 YES 24 G1 NO NO YES NO LSCS I 3 N N N N BA HOOD 3 DISCHARGE
42 MALLIGA 8088 MCH 39 3.26 NO 26 G2P1L1 NO NO NO NO LSCS O 4 N N N N MAS CPAP 10 DISCHARGE
43 NAGALAKSHMI 8250 MCH 38 2.1 YES 28 G3P1L1A1 PIH NO NO NO LN I 3 N N N N BA HOOD 4 DISCHARGE
44 RAMAJOTHI 8271 MCH 39 3.1 YES 19 G1 NO YES YES NO LN I 6 N N N N BA MV <1 DEATH
45 SARITHA 2261 MCH 38 2.27 YES 25 G1 NO YES YES NO OF O 3 N N N N BA MV 19 DISCHARGE
46 NANDHINI 1161 FCH 38 3.25 NO 23 G2P1L1 ANEMIA NO NO YES LSCS I 3 ABN N N N TTN HOOD 4 DISCHARGE
47 RANGESWARI 5634 FCH 39 3.5 NO 29 G1 PIH NO YES YES OF I 3 ABN N N N TTN HOOD 4 DISCHARGE
48 MUTHULAKSHMI 5256 MCH 37 3.47 YES 24 G3P1L1A1 PIH NO NO NO LSCS I 3 ABN N N N TTN HOOD 5 DISCHARGE
49 ANUSHYA 7290 FCH 38 2.6 NO 26 G2P1L1 NO NO NO NO LN I 3 N N N N O-CL&CP HOOD 8 DISCHARGE
50 RAJAMMAL 7654 FCH 38 3 NO 23 G1 ANEMIA NO YES YES LN I 2 N N N N BA HOOD 5 DISCHARGE
51 PARVATHI 7642 MCH 40 2.68 YES 26 G2P1L1 EPILEPSY NO NO YES OF I 4 ABN N N N MAS CPAP 8 DISCHARGE
52 ANNAPOORANI 6738 FCH 38 1.9 NO 23 G2P1L1 NO NO NO NO LSCS I 3 ABN N N ASD O-DOWNS HOOD 10 DISCHARGE
53 KOWSALYA 686 MCH 38 2.2 YES 21 G2P1L1 NO NO NO YES LN I 3 N N N N TTN HOOD 6 DISCHARGE
54 KANJANA 836 MCH 38 1.7 NO 25 G3P1L1A1 ANEMIA NO NO NO LSCS I 5 ABN N N N TTN CPAP 10 DISCHARGE
55 VELUTAHI 826 MCH 38 2.75 NO 29 G2P1L1 ANEMIA NO NO YES LSCS I 3 N N N N TTN HOOD 2 DISCHARGE
56 KALAIMAGAL 935 MCH 38 2 NO 23 G1 NO NO NO NO LN I 3 ABN N N N TTN HOOD 6 DISCHARGE
57 SABIRA FATHIMA 944 MCH 38 2.5 NO 29 G2 PIH NO NO NO LSCS I 3 N N N N TTN HOOD 5 DISCHARGE
58 MUTHUMANI 967 MCH 39 3.3 NO 24 G2A1 NO YES YES YES LSCS I 3 N N N N TTN HOOD 5 DISCHARGE
59 KANAKA 1107 FCH 38 2.7 YES 24 G3P2L1 NO NO NO NO LSCS I 6 ABN N N N O-OI MV 1 DEATH
60 DHAVAPRIYA 1123 MCH 38 3.2 YES 20 G2A1 PIH NO NO YES LN I 3 N N N N TTN HOOD 7 DISCHARGE
61 MUNEESWARI 991 FCH 38 3.06 NO 26 G2P1L1 NO NO NO NO LSCS I 3 N N N N O-LM HOOD 4 DISCHARGE
62 ABIRAMI 1214 MCH 38 2.25 NO 22 G3A2 ECLAMPSIANO NO NO LSCS I 3 N N N N O-LM HOOD 8 DISCHARGE
63 JEYAKODI 1259 FCH 38 2.6 YES 24 G1 ANEMIA NO NO YES OF I 2 ABN N N N TTN HOOD 4 DISCHARGE
64 PARVATHI 8257 FCH 38 2.7 NO 31 G6P5L3D2 NO NO NO YES LSCS I 3 ABN N N N TTN HOOD 2 DISCHARGE
65 SARANYA 8469 MCH 38 3 YES 21 G1 PIH NO NO NO LN I 5 N N N N BA CPAP 5 DISCHARGE
66 SOLAIESWARI 8483 FCH 38 2.8 YES 18 G1 ANEMIA YES NO NO LN I 3 ABN N N N TTN HOOD 4 DISCHARGE
67 MURUGESWARI 8521 FCH 39 3 NO 27 G1 NO NO NO YES OF O 5 ABN N N N MAS CPAP 7 DISCHARGE
68 MUTHESWARI 8622 MCH 38 2.49 YES 21 G4P2L2A1 NO NO NO YES LSCS I 5 N N N N BA MV 1 DEATH
69 KRISHNAVENI 8765 MCH 39 4.325 NO 27 G3P1L1A1 NO NO YES NO LN I 3 N N N N TTN HOOD 2 DISCHARGE
70 BANUPRIYA 8683 MCH 38 2.8 YES 20 G1 NO NO NO NO LN I 3 N N N N BA HOOD 4 DISCHARGE
71 KONAMMAL 7980 MCH 38 3 NO 26 G2P1L1 NO NO NO NO LSCS I 3 ABN N N N TTN HOOD 4 DISCHARGE
72 JEYAPRIYA 1612 FCH 38 2.6 YES 17 G1 NO NO NO NO LN I 3 N N N N BA HOOD 4 DISCHARGE
73 SEETHALAKSHMI 1625 MCH 38 3.1 YES 23 G2P1L1 ANEMIA NO NO NO LN I 3 N N N N BA HOOD 5 DISCHARGE
74 KASTHURI 1761 FCH 38 3 NO 21 G1 ANEMIA NO NO NO LSCS I 3 ABN N N N TTN HOOD 4 DISCHARGE
75 GOMATHI 1889 MCH 39 3.96 NO 34 G2P1A1 NO NO NO YES LSCS O 5 ABN N N N MAS CPAP 2 DISCHARGE
76 VEERAMANI 2236 MCH 40 3 YES 27 G4P2L2A1 PIH NO NO YES LN I 4 ABN N N N MAS CPAP 6 DISCHARGE
77 ARUNA 2244 MCH 37 2.27 YES 20 G1 ANEMIA NO NO NO LN I 3 N N N N BA CPAP 10 DISCHARGE
78 MANIMALA 2385 MCH 38 2.6 NO 29 G1 NO NO NO NO LN I 3 N N N N O-CL&CP HOOD 10 DISCHARGE
79 ALAGUMEENA 2428 FCH 37 2.39 YES 21 G1 NO NO NO NO LN O 4 N N N N BA HOOD 5 DISCHARGE
80 KAYALVIZHI 2545 MCH 38 2.1 NO 23 G3P1A1D1 NO NO NO NO LSCS I 3 N N N N TTN HOOD 6 DISCHARGE
81 VIJAYA 2700 FCH 39 2.67 NO 24 G1 ECLAMPSIANO NO NO LSCS I 2 ABN N N N TTN HOOD 5 DISCHARGE
82 SANGEETHA 2764 MCH 38 2.3 NO 20 G2A1 ANEMIA NO NO YES LSCS I 2 ABN N N N TTN HOOD 3 DISCHARGE
83 RANJITHA 2853 FCH 38 2.6 NO 22 G2P1L1 ANEMIA NO NO NO LSCS I 3 ABN N N N TTN HOOD 3 DISCHARGE
84 NAGAIINDRANI 2885 MCH 40 4.16 NO 30 G1 PIH NO NO NO LSCS I 3 N N N N TTN HOOD 3 DISCHARGE
85 KASTHURI 2918 FCH 39 3.08 NO 21 G1 PIH NO NO NO LSCS I 5 ABN N N N O-MM CPAP 4 DISCHARGE
86 MALLIGA 3188 MCH 39 3.05 YES 20 G1 ANEMIA NO NO YES LN O 6 ABN N N N MAS CPAP 10 DISCHARGE
87 CHELLATHA 3254 MCH 39 2.4 NO 22 G3P2L1A1 NO NO NO NO LN O 3 N N N PDA CHD HOOD 5 DISCHARGE
88 MARITHAI 3603 MCH 39 3.2 NO 20 G3P1L1A1 NO NO NO NO LSCS I 3 N N N N TTN HOOD 2 DISCHARGE
89 KANIMOZHI 3644 MCH 40 3.1 NO 29 G4P2L2A1 NO NO NO NO LSCS I 3 ABN N N N TTN HOOD 2 DISCHARGE
90 ASITHA 3793 FCH 37 2.4 NO 23 G1 NO NO NO NO LN I 3 N N N N O-MM HOOD 5 DISCHARGE
91 PANDIYAMMAL 3904 MCH 38 2.25 YES 20 G1 NO NO NO NO LSCS I 3 N N N N BA HOOD 4 DISCHARGE
92 NARMADHA 3948 FCH 38 2.5 NO 25 G4P3L1D2 NO NO NO NO LSCS I 3 ABN N N N TTN HOOD 4 DISCHARGE
93 BHARATHI 4064 MCH 40 3.485 NO 40 G3P1D1A1 HYPOTY NO NO NO LSCS I 3 N N N VSD CHD HOOD 5 DISCHARGE
94 RAVEENA 4198 FCH 38 2.65 YES 20 G1 NO NO YES YES LSCS O 7 ABN N N N MAS MV 4 DEATH
95 AMBIKA 4195 MCH 38 2.95 YES 22 G2P1L1 ANEMIA NO YES NO LN I 3 N N N N BA HOOD 5 DISCHARGE
96 JOTHILAKSHMI 4240 MCH 40 3.2 NO 20 G1 NO YES YES NO LSCS I 3 ABN N N N TTN HOOD 2 DISCHARGE
97 SARANYA 4294 MCH 39 2.4 NO 22 G1 ANEMIA NO NO NO LN I 3 ABN N N N TTN HOOD 3 DISCHARGE
98 SATHYAPRIYA 4316 MCH 40 3.95 NO 21 G1 PIH NO YES NO OF I 2 N N N N TTN HOOD 2 DISCHARGE
99 MUTHAMMAL 4341 FCH 39 2.64 YES 24 G2P1L1 UTI YES YES YES LN O 4 ABN N N N MAS MV 3 DEATH
100 GEETHALAKSHMI 4348 FCH 40 3.3 YES 26 G2P1L1 APH NO NO NO LN O 5 N N N N BA CPAP 7 DISCHARGE
101 JEYACHITRA 10914 MCH 38 3 YES 27 G3P1L1A1 NO NO NO NO LN O 4 N N N ASD CHD CPAP 15 DISCHARGE
102 SARANYA 10864 MCH 37 2.5 NO 25 G3P2L1 NO NO NO NO LSCS I 3 N N N N O-LM HOOD 10 DISCHARGE
103 JEYASUDHA 11043 FCH 40 3.1 NO 21 G2P1L1 NO NO NO YES LN O 5 ABN N N N MAS CPAP 5 DISCHARGE
104 MUTHUMANI 11069 FCH 40 2.81 YES 28 G2P1L1 NO NO NO NO LSCS I 6 N N N N BA CPAP 10 DISCHARGE
105 NAGAMMAL 11154 FCH 40 2.65 YES 28 G1 PIH NO NO NO LN O 5 N N N N BA CPAP 10 DISCHARGE
106 PRIYA 111045 FCH 37 2.4 NO 26 G5P3L1A1D2CI NO NO NO LN O 3 ABN N N TOF CHD HOOD 1 DISCHARGE
107 ESWARI 10632 MCH 37 2.2 NO 25 G2P1L1 NO YES YES NO LSCS I 3 ABN POS POS N SEPSIS HOOD 15 DISCHARGE
108 RAJESWARI 11341 MCH 40 3 NO 28 G4P1L1A2 NO NO NO NO LSCS I 3 N N N N TTN HOOD 2 DISCHARGE
109 ISPRIYA 11362 FCH 40 3 NO 25 G1 UTI YES YES NO LSCS I 4 ABN POS POS N SEPSIS CPAP 10 DISCHARGE
110 TAMILSELVI 11405 MCH 39 2.7 YES 29 G4P1L1A2 NO NO NO NO LN I 5 ABN N N TR CHD CPAP 6 DEATH
111 ABIRAMI 11406 MCH 40 2.95 YES 22 G1 NO NO NO YES LSCS I 6 ABN N N N MAS CPAP 6 DISCHARGE
112 MUTHUPAPPA 11486 MCH 40 3.02 YES 20 G2P1L1 NO NO NO NO LN I 4 N N N N BA CPAP 6 DISCHARGE
113 REKHA 11493 MCH 40 2.5 NO 22 G1 NO NO NO NO LN I 3 N N N N TTN HOOD 3 DISCHARGE
114 DHARANI 11494 MCH 37 2.1 YES 20 G1 PIH NO NO NO LN I 3 N N N N BA HOOD 6 DISCHARGE
115 MUTHULAKSHMI 11613 FCH 38 2.6 NO 27 G1 NO YES YES NO LN I 3 ABN N N N TTN HOOD 3 DISCHARGE
116 ANNAMMAL 11358 MCH 37 3 YES 35 G3P2L2A1 NO NO NO NO LSCS I 4 ABN N N CCHD CHD MV 2 DEATH
117 BOMMUTHAI 11953 FCH 37 3 NO 22 G2P1L1 NO NO NO YES LSCS I 3 ABN N N N MAS HOOD 3 DISCHARGE
118 MUTHULAKSHMI 12483 MCH 37 2.4 NO 20 G1 NO YES YES NO LN I 3 ABN POS POS N SEPSIS HOOD 10 DISCHARGE
119 NANDHINI 12447 MCH 40 4 NO 25 G2P1L1 PIH NO NO NO LSCS I 3 N N N N TTN HOOD 5 DISCHARGE
120 ANGALESHWARI 12676 FCH 39 3.03 NO 20 G1 NO NO NO YES LSCS I 7 ABN N N N MAS CPAP 12 DISCHARGE
121 ATHESWARI 12832 MCH 39 3.2 YES 20 G1 PIH NO NO YES LN O 5 ABN N N N MAS CPAP 12 DISCHARGE
122 NIVETHA 13328 MCH 39 3.2 NO 22 G1 NO YES YES NO LSCS I 3 N POS POS N SEPSIS HOOD 10 DISCHARGE
123 ANANDHI 13421 FCH 38 3.04 YES 22 G1 NO NO NO YES LSCS I 6 ABN N N N MAS MV 2 DEATH
124 SATHYA 13442 FCH 40 3.15 YES 22 G2P1L1 NO NO NO YES LN I 3 N POS POS N SEPSIS HOOD 10 DISCHARGE
125 SUBBULAKSHMI 13539 FCH 39 3.7 YES 19 G1 NO YES YES NO OF I 4 N N N N BA MV 13 DISCHARGE
126 MENAKA 13598 MCH 38 2.84 YES 22 G1 NO NO NO YES LN O 7 ABN N N N MAS MV 22 DEATH
127 SELVARANI 13610 MCH 39 2.7 YES 24 G4P3L1D2 NO NO NO NO OF I 3 ABN POS POS N SEPSIS CPAP 11 DISCHARGE
128 SUJITHA 13659 MCH 38 2.8 NO 25 G2P1L1 NO NO NO NO LSCS O 6 ABN N N N PN MV 4 DEATH
129 RENUKA 13680 FCH 38 2.9 NO 26 G2P1L1 NO NO NO YES LN O 3 N N N N TTN HOOD 5 DISCHARGE
130 SHANMUGAPRIYA 13697 MCH 40 3.3 NO 23 G1 NO NO NO NO LN O 3 N N N N O-CL&CP HOOD 6 DISCHARGE
131 PANDISELVI 13751 MCH 38 2.7 YES 23 G2P1L1 NO NO NO NO LN I 5 N N N N BA MV 8 DEATH
132 JEYAPRIYA 13765 MCH 38 2.9 YES 19 G1 NO NO NO NO LN I 5 ABN POS POS N SEPSIS HOOD 12 DISCHARGE
133 DIVYA 13790 MCH 37 3 NO 23 G1 NO NO NO YES LSCS I 6 ABN N N N MAS HOOD 8 DISCHARGE
134 KARPAGAM 13805 FCH 38 3.3 NO 23 G2P1L1 NO NO NO NO LN O 5 ABN POS POS N PN CPAP 10 DISCHARGE
135 MANISHA 13757 MCH 37 2.5 NO 19 G1 NO NO NO NO LSCS I 4 N N N ASD CHD CPAP 9 DISCHARGE
136 ALAGAMMAL 13848 MCH 39 3.2 NO 30 G2P1L1 NO NO NO NO LSCS I 3 N N N N TTN HOOD 3 DISCHARGE
137 DHANALAKSHMI 13914 FCH 37 2.6 NO 24 G3P2L2A1 NO NO NO YES LSCS I 5 ABN N N N MAS CPAP 4 DISCHARGE
138 NANDHINI 13936 FCH 38 2.8 NO 24 G3P1L1A1 NO NO NO NO LSCS I 3 ABN N N ASD CHD HOOD 8 DISCHARGE
139 RAJAKUMARI 14024 MCH 39 3.4 YES 22 G1 NO NO NO NO LN O 3 N N N N BA HOOD 5 DISCHARGE
140 JOTHI 14101 FCH 38 2.8 NO 24 G1 PIH NO NO NO OF I 3 ABN N N N TTN HOOD 3 DISCHARGE
141 ILAVARASI 14148 MCH 39 3.17 NO 29 G2P1L1 NO NO NO NO LSCS I 3 N N N N TTN HOOD 3 DISCHARGE
142 NAGESWARI 14208 MCH 40 2.75 NO 19 G1 NO YES YES YES LN O 4 ABN N N N MAS CPAP 6 DISCHARGE
143 ANITHA 14355 FCH 39 3.78 NO 26 G2P1L1 PIH NO NO YES LSCS I 3 N N N N TTN HOOD 3 DISCHARGE
144 ALAGULAKSHMI 14372 MCH 38 3 YES 18 G1 NO NO NO NO LN I 6 N N N N BA CPAP 12 DISCHARGE
145 MAHESWARI 14488 MCH 40 2.96 NO 21 G1 NO NO NO YES LN I 6 ABN N N PPHN MAS MV 3 DEATH
146 RAJASELVI 14714 MCH 39 3.1 NO 21 G1 NO NO NO NO LN I 3 N N N N TTN HOOD 3 DISCHARGE
147 TAMILARASI 14852 MCH 38 4.15 NO 33 G2P1L1 NO NO NO NO LSCS O 3 N N N PDA CHD HOOD 6 DISCHARGE
148 RUKUMANI 15109 MCH 40 3.8 NO 30 G2P1L1 NO NO NO NO LSCS O 6 ABN N N PPHN MAS CPAP 7 DISCHARGE
149 MUTHULAKSHMI 15156 MCH 38 3 YES 21 G1 NO NO NO NO LN O 6 N N N N BA MV 2 DEATH
150 VINODHINI 15133 MCH 39 2.9 NO 21 G2P1L1 NO NO NO NO LN I 3 ABN N N N TTN HOOD 3 DISCHARGE
151 MURUGESWARI 15228 MCH 38 2.6 YES 19 G1 NO YES YES NO LN O 5 N N N N BA MV 10 DEATH
152 PALMANI 15242 MCH 38 3.17 YES 22 G2P1L1 NO NO NO NO LSCS I 3 N N N N BA HOOD 4 DISCHARGE
153 PANDIMEENA 15069 FCH 39 3 NO 25 G5P2L1A2D1NO NO NO NO LN I 4 ABN N N ASD CHD CPAP 11 DISCHARGE
154 NAGAMANI 15355 MCH 39 3.3 YES 20 G3P1L1A1 NO YES YES NO LN O 3 N N N N BA HOOD 6 DISCHARGE
155 ATHILAKSHMI 15373 FCH 38 2.1 NO 19 G1 UTI YES YES NO LN I 6 ABN N N N PN MV 1 DEATH
156 MUTHULAKSHMI 15156 MCH 38 3 NO 21 G1 NO NO NO NO LN O 3 N N N N BA HOOD 3 DISCHARGE
157 SURYAKALA 15540 MCH 40 2.7 NO 24 G1 PIH YES YES YES LSCS I 3 N POS POS N SEPSIS HOOD 14 DISCHARGE
158 MALLIGA 15579 MCH 39 3 YES 19 G1 NO NO YES NO LN I 3 N N N N BA HOOD 4 DISCHARGE
159 BAKIYALAKSHMI 15583 MCH 39 3.2 YES 22 G2P1L1 GDM YES YES NO LSCS I 3 N POS POS N SEPSIS HOOD 14 DISCHARGE
160 MANIMEGALAI 15586 MCH 37 2.2 NO 35 G1 NO NO NO YES LSCS O 3 ABN N N N MAS HOOD 3 DISCHARGE
161 RAMYA 15647 MCH 38 2.69 YES 29 G1 NO YES YES NO LN I 6 N POS POS N SEPSIS CPAP 14 DISCHARGE
162 UMAPATHI 15581 MCH 39 2.8 NO 26 G4P2L2A1 ANEMIA NO NO NO LN I 3 N N N N TTN HOOD 2 DISCHARGE
163 PANDISELVI 15808 MCH 38 3.3 YES 19 G1 NO NO YES NO LN I 3 N N N N BA HOOD 4 DISCHARGE
164 MONISHA 15601 MCH 39 2.9 NO 23 G1 ANEMIA NO NO NO LSCS I 3 ABN N N PDA CHD HOOD 6 DISCHARGE
165 MEENA 16028 FCH 39 3 NO 28 G5P1L1A3 GDM NO NO NO LSCS I 4 ABN N N PDA CHD CPAP 13 DISCHARGE
166 SANGEETHA 16259 MCH 38 2.2 NO 19 G1 NO NO NO YES LSCS I 3 N N N N TTN HOOD 3 DISCHARGE
167 ALAGUPANDIYAMMAL 16338 FCH 39 3.1 YES 25 G2P1L1 NO YES YES YES LN I 7 ABN N N N MAS MV 4 DEATH
168 LOKESHWARI 16362 FCH 39 2.75 NO 24 G1 NO NO YES YES LSCS I 5 N POS POS N SEPSIS CPAP 14 DISCHARGE
169 KRISHNAVENI 16386 FCH 40 3.81 NO 21 G1 NO YES NO YES LSCS I 3 N N N PDA CHD CPAP 13 DISCHARGE
170 NITHYA 16394 MCH 40 3.2 YES 27 G1 SD YES YES NO LSCS O 7 N N N N BA MV <1 DEATH
171 ASHADEVI 16413 MCH 37 2.25 YES 23 G1 PIH NO YES NO LN I 5 N POS POS N SEPSIS CPAP 12 DISCHARGE
172 RANI 16496 MCH 39 2.75 YES 30 G2P1L1 ANEMIA NO NO NO LN I 3 N N N N BA HOOD 5 DISCHARGE
173 ARCHANA 16541 FCH 39 3.9 YES 17 G1 ANEMIA NO NO NO LN I 3 N N N N BA HOOD 4 DISCHARGE
174 SELVAMANI 8736 MCH 38 2.33 NO 21 G2P1L1 NO NO NO NO LSCS I 3 ABN N N N O-TEF HOOD 1 DISCHARGE
175 MADHUBALA 8782 FCH 39 2.3 YES 23 G2P1L1 NO NO YES YES LSCS I 3 N N N N BA HOOD 3 DISCHARGE
176 RAJAMANI 8807 MCH 38 2.25 NO 20 G1 ANEMIA YES YES NO OF I 3 N POS POS N SEPSIS HOOD 10 DISCHARGE
177 PANDIAMMAL 8820 FCH 40 3.5 NO 22 G1 NO NO NO NO OF I 3 ABN N N N TTN HOOD 3 DISCHARGE
178 MARIAMMAL 8826 FCH 38 2.7 NO 23 G2P1L1 NO NO NO NO LSCS I 3 N N N N TTN HOOD 3 DISCHARGE
179 INDIRA 8875 MCH 40 2.65 YES 24 G1 NO YES YES NO LN I 5 ABN POS POS N SEPSIS CPAP 19 DISCHARGE
180 VIMALA 8925 FCH 38 2.33 NO 25 G2P1L1 NO NO NO NO LSCS I 3 ABN N N VSD CHD HOOD 10 DISCHARGE
181 ELIZARASI 8985 MCH 38 2.3 NO 27 G1 UTI YES YES NO LSCS O 3 N POS POS N SEPSIS HOOD 13 DISCHARGE
182 MALLIGA 9027 MCH 38 2.3 NO 32 G2A1 NO NO NO YES LSCS I 6 ABN N N N MAS CPAP 7 DISCHARGE
183 SUVETHA 9037 FCH 39 3 YES 19 G1 NO NO YES NO OF I 5 N N N N BA CPAP 7 DISCHARGE
184 KASTHURI 9121 MCH 39 3 YES 23 G2P1L1 ANEMIA YES YES NO LN O 3 N POS POS N SEPSIS HOOD 11 DISCHARGE
185 AMIRTHA JOTHI 9229 MCH 39 3.19 NO 29 G4P2L2A1 NO NO NO NO LSCS I 3 N N N N TTN HOOD 4 DISCHARGE
186 KAYALVIZHI 9322 MCH 39 3.1 NO 23 G2A1 GDM NO NO NO LSCS I 3 ABN N N N TTN HOOD 5 DISCHARGE
187 NAGABHAVANI 9370 MCH 38 3.8 NO 24 G4P1L1A2 PIH NO NO NO LSCS I 3 ABN N N N TTN HOOD 3 DISCHARGE
188 NANDHINI 9444 FCH 39 3.15 YES 22 G2P1L1 NO NO NO NO LN I 6 N N N N BA HOOD 6 DISCHARGE
189 TAMILSELVI 9510 MCH 38 2.6 NO 28 G4P3L3 GDM NO NO NO LN I 2 N N N N TTN HOOD 6 DISCHARGE
190 KEERTHANA 9685 MCH 37 2.14 NO 21 G1 NO NO NO YES LSCS O 5 ABN N N N MAS CPAP 5 DISCHARGE
191 RAMAYEE 9692 FCH 37 1.65 NO 23 G3A2 PIH NO NO NO LN I 3 N N N PDA CHD HOOD 10 DISCHARGE
192 REVATHY 9790 MCH 38 2.39 NO 23 G1 NO NO NO NO LN O 2 N N N N TTN HOOD 6 DISCHARGE
193 KANDHAMANI 9818 FCH 38 2.5 NO 24 G2P1L1 NO NO NO NO LN O 3 N N N N TTN HOOD 3 DISCHARGE
194 MOUNIKA 9916 FCH 37 3.125 NO 20 G1 GDM/PIH NO NO NO LSCS I 3 ABN N N VSD CHD HOOD 3 DISCHARGE
195 RUBASREE 10007 MCH 37 3.3 YES 20 G1 NO NO NO NO LN I 3 N N N N BA HOOD 3 DISCHARGE
196 MALATHI 10032 FCH 37 2.23 YES 24 G2P1L1 NO NO NO NO LSCS I 3 N N N N BA HOOD 4 DISCHARGE
197 MUTHUMARIYAMMAL 10026 FCH 39 2.9 NO 22 G1 NO YES YES NO LN I 3 N N N N TTN HOOD 3 DISCHARGE
198 SUGANTHI 10038 FCH 39 3.12 NO 25 G3P2L1A1 NO NO NO NO LSCS O 5 ABN N N N PN CPAP 10 DISCHARGE
199 VIJAYA 10285 MCH 37 3.365 NO 22 G2P1L1 NO NO NO NO LN I 3 N N N N TTN HOOD 3 DISCHARGE
200 APARNA 10289 MCH 38 2.88 NO 20 G2P1L1 PIH NO NO NO LSCS O 3 N N N N TTN HOOD 4 DISCHARGE
201 DEVI 10298 MCH 39 3 NO 30 G3P1L1A1 NO NO NO YES LSCS I 6 ABN N N N MAS CPAP 4 DISCHARGE
202 SUGAPRIYA 10370 MCH 39 3.25 YES 23 G2A1 PIH NO NO YES LSCS I 4 N N N N TTN HOOD 8 DISCHARGE
203 SUMITHRA 10360 MCH 38 2.25 NO 25 G2A1 ANEMIA NO NO YES LSCS I 6 N N N N O-CM MV 19 DEATH
204 THENMOZHI 10386 FCH 38 2.5 NO 29 G1 PIH NO NO YES LSCS I 3 ABN N N N MAS HOOD 5 DISCHARGE
205 MAHESWARI 10423 MCH 38 3.59 NO 38 G2P1L1 GDM NO NO NO LSCS I 4 N N N N TTN HOOD 4 DISCHARGE
206 MURUGESWARI 10468 FCH 38 3.16 YES 22 G1 NO YES YES NO LSCS I 5 N N N N BA CPAP 13 DISCHARGE
207 NIVETHA 10654 MCH 39 3 NO 22 G1 NO YES YES NO LN I 3 N POS POS N SEPSIS HOOD 10 DISCHARGE
208 CHELLAMMAL 10735 MCH 39 2.9 NO 19 G1 NO NO NO NO LN I 3 N N N N TTN HOOD 4 DISCHARGE
209 SELVALAKSHMI 16625 FCH 39 3.45 NO 22 G2P1L1 NO NO NO NO LN O 3 ABN N N N TTN HOOD 3 DISCHARGE
210 KANAGAVALLI 16665 MCH 39 3.5 NO 20 G2P1L1 NO NO NO NO LSCS I 4 N N N N TTN HOOD 3 DISCHARGE
211 NAGAJOTHI 16854 MCH 38 2.6 NO 21 G2P1L1 NO YES YES NO LN I 5 ABN POS POS N SEPSIS CPAP 10 DISCHARGE
212 RAJINA BANU 16914 MCH 38 4.2 NO 25 G3P1L1A1 GDM NO NO NO LSCS I 3 N N N N TTN HOOD 4 DISCHARGE
213 KAMUTHAI 16905 FCH 39 3.1 YES 33 G4P3L3 NO NO YES NO LN I 3 N N N N BA HOOD 5 DISCHARGE
214 SHANTHI 16592 MCH 39 2.39 NO 30 G3P1L1A1 NO NO NO NO LSCS I 3 N N N N TTN HOOD 4 DISCHARGE
215 GOWSALYA 16983 MCH 38 2.56 YES 19 G1 NO NO YES NO LN I 3 N POS POS N SEPSIS HOOD 10 DISCHARGE
216 ESWARI 17194 MCH 39 2.63 NO 25 G3P1L1A1 NO NO NO NO LN O 4 N N N PDA CHD HOOD 3 DISCHARGE
217 ALGURANI 17230 MCH 37 2.4 NO 23 G1 NO NO NO YES LN O 6 ABN N N N MAS CPAP 7 DISCHARGE
218 ANGALESHWARI 17357 FCH 38 2.6 YES 22 G2P1D1 NO NO NO NO LSCS I 6 N N N N BA CPAP 7 DISCHARGE
219 DIVYA 17299 MCH 40 3.1 NO 20 G1 NO NO NO YES LSCS I 3 ABN N N N MAS HOOD 10 DISCHARGE
220 NIHARAPARVEEN 17432 MCH 39 3.11 YES 24 G1 ANEMIA YES YES NO LN I 3 N POS POS N SEPSIS HOOD 12 DISCHARGE
221 PALANIYAMMAL 17590 FCH 39 3.44 YES 26 G3P1L1A1 NO YES YES NO LN I 3 N POS POS N SEPSIS HOOD 7 DISCHARGE
222 PREETHI 17600 MCH 39 3.2 YES 22 G3P1L1A2 NO NO NO YES LSCS I 3 N N N N BA HOOD 5 DISCHARGE
223 RAJESWARI 17664 MCH 38 2.25 NO 26 G2P1L1 NO NO NO NO LSCS I 3 N N N N TTN HOOD 6 DISCHARGE
224 BEAULA SELVARANI 17679 FCH 40 2.8 NO 21 G1 NO NO NO NO LN I 3 N POS POS N SEPSIS HOOD 10 DISCHARGE
225 SUBBULAKSHMI 17915 FCH 38 2.75 NO 24 G2P1L1 NO NO NO NO LSCS I 3 N N N N TTN HOOD 3 DISCHARGE
226 GEETHA 17987 FCH 40 2.6 NO 19 G1 NO NO NO NO LN I 3 ABN N N N TTN HOOD 3 DISCHARGE
227 JEYANTHI 17970 MCH 40 2.75 NO 26 G2A1 NO NO NO NO LSCS I 3 N N N N TTN HOOD 3 DISCHARGE
228 MURUGESWARI 18185 MCH 38 3.9 NO 26 G2P1L1 GDM NO NO NO LSCS I 3 N N N PDA CHD HOOD 5 DISCHARGE
229 KRISHNAVENI 18291 FCH 38 2.6 YES 28 G2P1L1 NO NO NO NO LN O 6 N N N N BA CPAP 6 DISCHARGE
230 SATHYAPRIYA 18282 MCH 40 3.55 YES 29 G2P1L1 NO NO NO NO OF I 5 N N N N BA CPAP 3 DISCHARGE
231 VANITHA 18329 MCH 39 2.99 YES 21 G1 NO YES YES NO LSCS I 7 N N N N BA MV 2 DEATH
232 INDIRA 18324 MCH 39 2.6 YES 27 G1 HYPOTY YES YES NO LSCS I 5 N N N N BA CPAP 4 DISCHARGE
233 CHANDRALEKHA 18323 FCH 40 2.75 NO 28 G2A1 RHD NO NO NO LSCS I 3 N N N N TTN HOOD 3 DISCHARGE
234 JOTHILAKSHMI 18467 MCH 39 3.15 YES 32 G2A1 NO YES YES NO LN I 3 N POS POS N BA HOOD 10 DISCHARGE
235 NATHIYA 18469 FCH 39 3.5 YES 27 G3P2L1A1 NO YES YES NO LSCS I 8 N N N N BA MV <1 DEATH
236 ROOBINI 18556 FCH 37 3.65 NO 27 G1 NO NO NO NO LSCS I 3 N N N N TTN HOOD 3 DISCHARGE
237 GOWRI 18594 FCH 38 2.5 NO 20 G1 NO NO NO NO LN O 3 N POS POS ASD CHD HOOD 7 DISCHARGE
238 VIDHYA 18617 FCH 40 2.8 NO 21 G2A1 PIH NO NO NO LN O 3 ABN N N N MAS HOOD 3 DISCHARGE
239 KAMALI 18787 MCH 38 3 NO 20 G1 GDM NO NO NO LSCS I 3 N N N PDA CHD HOOD 6 DISCHARGE
240 UMAMAHESHWARI 18824 FCH 38 2.5 NO 31 G2P1L1 ANEMIA NO NO NO LSCS I 3 ABN N N N TTN HOOD 5 DISCHARGE
241 KAVITHA 18522 FCH 37 2.3 NO 25 G3P1L1A1 NO NO NO NO LSCS I 4 ABN N N VSD CHD HOOD 6 DISCHARGE
242 VELANKANNI 19004 MCH 39 2.6 NO 27 G2A1 PIH NO NO YES LSCS I 3 ABN N N N MAS HOOD 5 DISCHARGE
243 NANDHINI 19002 FCH 40 2.5 NO 24 G3P1L1A1 NO NO NO NO LSCS I 2 N N N N TTN HOOD 3 DISCHARGE
244 VANITHA 19089 MCH 39 2.68 YES 20 G1 NO YES YES YES LN O 7 ABN N N N MAS MV 2 DEATH
245 THILAGAVENI 19164 MCH 40 3.35 NO 19 G1 NO NO NO YES LN I 5 ABN N N N MAS CPAP 5 DISCHARGE
246 NARMADHA DEVI 19211 MCH 39 3.48 NO 20 G1 NO NO NO NO LSCS O 4 ABN N N PDA CHD CPAP 5 DISCHARGE
247 ROSHMA 19307 FCH 38 2 NO 20 G1 NO NO NO NO LN O 3 N N N PDA CHD HOOD 4 DISCHARGE
248 SATHYA 19300 MCH 39 2.3 NO 23 G2A1 NO NO NO NO LN I 5 N N N TGA CHD CPAP <1 DEATH
249 NIRANJANA DEVI 19725 FCH 38 2.68 YES 25 G2P1L1 NO NO YES NO LN I 3 N N N N BA HOOD 5 DISCHARGE
250 MUTHULAKSHMI 19836 FCH 38 2.4 NO 22 G1 HYPOTY NO NO NO LN I 3 N N N N TTN HOOD 6 DISCHARGE
251 SATHYA 19908 MCH 40 4 NO 23 G4P1L1A2 NO NO NO NO LSCS I 2 N N N N TTN HOOD 3 DISCHARGE
252 ESWARI 20053 MCH 40 4 NO 21 G2P1D1 NO NO NO NO LSCS I 2 N N N PDA CHD HOOD 4 DISCHARGE
253 AYYAMMAL 20171 MCH 38 2.4 NO 22 G1 NO NO NO NO LN O 3 N POS POS PDA SEPSIS HOOD 14 DISCHARGE
254 PRIYA 20325 MCH 40 2.44 NO 28 G4P1L1A2 ANEMIA NO NO NO LN O 3 ABN N N N TTN HOOD 6 DISCHARGE
255 MAREESWARI 20411 MCH 40 2.75 NO 28 G3P2L2 NO NO NO NO LSCS I 5 ABN N N N MAS CPAP 7 DISCHARGE
256 MUTHULAKSHMI 20429 FCH 37 2.5 NO 29 G3P2L2 NO NO NO YES LN I 3 N N N N TTN HOOD 3 DISCHARGE
257 LAKSHMI 20457 MCH 40 2.75 YES 26 G2P1L1 NO NO NO NO LN I 7 ABN N N N BA MV 2 DEATH
258 NAGALAKSHMI 20784 FCH 38 3.2 YES 21 G1 ANEMIA NO NO NO LSCS I 5 ABN N N N BA CPAP 10 DISCHARGE
259 PAWNMANI 20827 FCH 40 2.75 YES 35 G3P2L1D1 NO YES YES NO LN I 6 ABN POS POS N SEPSIS CPAP 14 DISCHARGE
260 ANBARASI 20869 FCH 38 2.7 YES 19 G1 NO NO NO NO LN I 3 N N N N BA HOOD 8 DISCHARGE
261 NAGAJOTHI 20957 FCH 40 3.65 NO 25 G2P1L1 NO YES YES NO LSCS I 3 N POS POS N SEPSIS HOOD 12 DISCHARGE
262 SEETHALAKSHMI 21238 FCH 38 2.7 NO 18 G1 NO NO NO YES LSCS I 5 ABN N N N MAS CPAP 12 DISCHARGE
263 KANIGADEVI 21266 MCH 39 3.25 NO 27 G1 NO NO NO NO LN O 3 N N N PDA CHD HOOD 3 DISCHARGE
264 CHANDRA 21312 MCH 37 4.2 NO 30 G3P1L1A1 NO YES YES NO LSCS I 3 ABN N N PDA CHD HOOD 6 DISCHARGE
265 ROHINI 21318 FCH 39 3.18 NO 23 G2P1L1 NO NO NO NO LN O 3 N N N PHT CHD HOOD 3 DISCHARGE
266 INDIRANI 22070 FCH 38 2.76 YES 27 G2P1L1 NO NO NO YES LSCS I 3 N N N N BA HOOD 7 DISCHARGE
267 BAIRAVI 22082 FCH 40 2.93 YES 23 G1 NO NO NO YES LN O 3 N N N N BA HOOD 5 DISCHARGE
268 KALAIYARASI 22143 FCH 37 2.5 NO 32 G1 GDM NO NO NO LSCS I 3 N N N ASD CHD HOOD 10 DISCHARGE
269 PARAMESWARI 22267 MCH 40 3 NO 26 G3P2L2 NO NO NO NO OF I 3 N N N N TTN HOOD 3 DISCHARGE
270 THENMOZHI 22283 MCH 39 2.75 YES 19 G1 NO NO NO YES LN I 3 ABN N N N MAS HOOD 2 DISCHARGE
271 MUTHUMEENA 22309 MCH 37 2.99 NO 28 G2P1L1 NO YES NO NO LSCS I 5 ABN POS POS N SEPSIS CPAP 14 DISCHARGE
272 MURUGESWARI 22423 FCH 37 1.7 NO 28 G2P1L1 NO NO NO NO LN I 3 N N N N TTN HOOD 3 DISCHARGE
273 RANI 22033 MCH 40 3.87 YES 26 G2A1 CHD NO NO NO LSCS I 6 N N N N BA CPAP 10 DISCHARGE
274 PANDEESWARI 20560 FCH 38 1.59 NO 20 G1 NO NO NO YES LN O 5 ABN N N N MAS CPAP 9 DISCHARGE
275 ANNALAKSHMI 22573 MCH 38 2.89 NO 21 G2P1L1 NO NO NO YES LN O 3 N POS POS N SEPSIS HOOD 12 DISCHARGE
276 KARPAGAM 22565 MCH 39 2.75 NO 25 G1 NO NO NO YES LSCS I 3 N N N N TTN HOOD 4 DISCHARGE
277 SATHYA 40296 FCH 38 2.6 YES 25 G3P1L1A1 NO NO NO NO LSCS I 4 N N N N BA CPAP 9 DISCHARGE
278 SARADHA 40479 FCH 38 2.79 YES 25 G3P2L2 NO NO NO NO LN O 5 N N N N BA CPAP 10 DISCHARGE
279 SYED ALI FATHIMA 40589 MCH 37 1.75 NO 20 G1 NO NO NO NO LSCS I 3 N N N N TTN HOOD 4 DISCHARGE
280 SUJITHA 40689 MCH 39 3.2 NO 40 G3P1L1A1 NO NO NO YES LSCS I 4 ABN N N N MAS CPAP 10 DISCHARGE
281 MAREESWARI 40534 MCH 39 3.2 NO 18 G1 NO NO NO YES LSCS I 4 ABN N N N MAS CPAP 7 DISCHARGE
282 PANDIYAMMAL 40459 MCH 40 3.04 NO 18 G1 NO NO NO YES LSCS I 4 ABN N N N MAS CPAP 8 DISCHARGE
283 NAGAJOTHI 40561 FCH 40 3.15 NO 18 G1 NO NO NO YES LSCS I 4 N N N N MAS CPAP 9 DISCHARGE
284 PUSHPALATHA 40572 FCH 40 3.7 NO 18 G1 NO NO NO YES LSCS I 6 ABN N N PPHN MAS MV 2 DEATH
285 ABIRAMI 40627 MCH 38 2.4 NO 27 G2A1 NO NO NO NO LSCS I 2 N N N N TTN HOOD 3 DISCHARGE
286 RANJANI 40753 MCH 37 3.4 NO 29 G2P1L1 PIH NO NO NO LSCS I 3 N N N PDA CHD HOOD 4 DISCHARGE
287 JEYASHEELA 40755 MCH 38 3.25 NO 24 G3P2L2 NO NO NO NO LN O 3 ABN POS POS N SEPSIS HOOD 14 DISCHARGE
288 JEYAPRIYA 40759 MCH 37 2.4 NO 20 G1 PIH NO NO NO LN I 3 N N N N TTN HOOD 4 DISCHARGE
289 BACHIYALAKSHMI 40867 MCH 38 2.37 NO 26 G2P1L1 NO NO NO NO LSCS I 4 N N N N TTN CPAP 4 DISCHARGE
290 GANDHIMATHI 40889 MCH 38 2.97 NO 23 G1 ANEMIA NO NO NO LN I 5 ABN N N PHT CHD CPAP 1 DISCHARGE
291 SANGEETHA 41110 MCH 39 3 YES 28 G2P1L1 HYPOTY NO NO NO LN O 5 N N N N BA CPAP 8 DISCHARGE
292 NAGAJOTHI 41145 MCH 38 2.8 NO 28 G3P2L2 ANEMIA NO NO YES LN O 4 ABN N N N MAS CPAP 7 DISCHARGE
293 ANUSHYA 41156 FCH 39 2.45 YES 19 G2P1L1 NO NO NO YES LSCS O 5 ABN N N N MAS CPAP 14 DISCHARGE
294 ANUSHYA 41195 FCH 38 2.5 YES 21 G1 PIH NO NO NO LSCS I 4 N N N N BA CPAP 9 DISCHARGE
295 SUJATHA 41366 MCH 38 3 NO 25 G1 NO NO NO YES LN I 5 ABN N N N MAS CPAP 8 DISCHARGE
296 NAGALAKSHMI 41521 MCH 40 3.08 YES 20 G1 NO NO NO YES OF I 6 ABN N N PPHN MAS MV 3 DEATH
297 GAYATHRI 41395 MCH 38 3.25 NO 22 G3A2 EPILEPSY YES YES NO LN I 3 N POS POS N SEPSIS HOOD 14 DISCHARGE
298 LINGAMMAL 41676 FCH 39 3.19 NO 25 G2P1L1 NO NO NO NO LN I 3 N N N N TTN HOOD 4 DISCHARGE
299 KARTHIGAI JOTHI 41839 MCH 38 2.68 NO 20 G1 NO NO NO NO LN I 3 N N N N TTN HOOD 3 DISCHARGE
300 DHANALAKSHMI 41847 FCH 40 3.84 NO 22 G2P1L1 NO NO NO YES LSCS I 3 N N N N TTN HOOD 3 DISCHARGE
301 VASUKI 42089 FCH 40 3.3 YES 22 G1 NO NO NO NO LN O 7 N N N N BA MV 8 DEATH
302 POTHUMANI 42084 MCH 38 2.2 NO 24 G2P1L1 PIH NO NO YES LN I 5 ABN N N N MAS CPAP 9 DISCHARGE
303 JOTHILAKSHMI 42388 FCH 39 2.87 YES 19 G1 NO NO NO YES LN O 5 ABN N N N BA CPAP 8 DISCHARGE
304 SANGEETHA 42299 MCH 40 3.4 NO 19 G1 NO NO NO YES LSCS I 3 N N N N TTN HOOD 3 DISCHARGE
305 SRIDEVI 42509 FCH 38 2.3 YES 18 G1 NO NO YES NO OF I 4 N N N N BA CPAP 8 DISCHARGE
306 PRIYA 42522 MCH 39 2.7 NO 21 G1 NO NO NO NO LN I 4 N N N N TTN CPAP 4 DISCHARGE
307 ISWARIYA 42586 FCH 39 2.95 NO 20 G1 NO NO NO NO LN I 2 N N N N TTN HOOD 3 DISCHARGE
308 SURYAKALA 42611 FCH 40 3.4 NO 24 G2A1 PIH NO NO YES LSCS I 5 ABN N N N MAS CPAP 8 DISCHARGE
309 GEETHALAKSHMI 42784 FCH 40 3.42 NO 27 G3P2L2 NO NO NO NO LSCS I 3 N N N N TTN HOOD 3 DISCHARGE
310 VIJAYALAKSHMI 42856 FCH 39 3.56 YES 20 G1 NO NO NO NO LN O 5 N N N N BA CPAP 12 DISCHARGE
311 DEVI 42941 FCH 37 2.25 NO 28 G1 NO NO NO NO LN I 3 N N N N O-COLLODION HOOD 5 DISCHARGE
312 MANIMEGALAI 42992 MCH 38 2.66 NO 23 G1 NO YES NO YES LN I 3 N N N N TTN HOOD 4 DISCHARGE
313 ANITHA KELEN 42996 MCH 40 3.25 NO 28 G1 NO NO NO NO LN I 3 N N N N TTN HOOD 3 DISCHARGE
314 ELISARANI 43085 MCH 39 3.57 NO 29 G2A1 NO NO NO NO LSCS I 3 N N N N TTN HOOD 3 DISCHARGE
315 SARANYA 43320 MCH 40 3.7 NO 23 G2P1L1 NO NO NO YES LN I 4 ABN N N N MAS CPAP 7 DISCHARGE
316 BETHANAKSHI 43337 MCH 37 2.1 NO 30 G4P2L1A1 NO NO NO NO LN O 3 N N N N O-EDWARD HOOD 5 DISCHARGE
317 MARIAMMAL 43370 FCH 38 2.4 YES 24 G2P1L1 NO NO NO NO LSCS O 5 N N N N BA CPAP 8 DISCHARGE
318 POORNASUNDARI 43447 FCH 38 2.75 NO 25 G2P1L1 NO NO NO NO LSCS I 3 N N N N TTN HOOD 3 DISCHARGE
319 GNANAMANI 43412 FCH 39 2.9 NO 20 G2A1 NO NO NO NO LN I 3 N N N N TTN HOOD 3 DISCHARGE
320 NEELAVATHI 43521 FCH 40 2.3 NO 25 G1 NO NO NO YES OF I 4 N N N N TTN CPAP 4 DISCHARGE
321 SATHYA 43664 MCH 37 2.42 NO 20 G1 ANEMIA NO NO NO LN I 3 N N N N TTN HOOD 3 DISCHARGE
322 SANTHIYA 43751 MCH 38 2.53 NO 25 G1 PIH YES NO NO LSCS I 4 N N N N TTN CPAP 4 DISCHARGE
323 MALATHI 43924 MCH 38 3.6 NO 22 G2A1 NO YES YES NO OF I 2 N N N N TTN HOOD 3 DISCHARGE
324 KAVERI 48842 FCH 38 3 NO 24 G3P1L1A1 NO NO NO NO LSCS I 3 N N N N TTN HOOD 3 DISCHARGE
325 MUTHALAMMAL 49008 FCH 40 2.75 NO 19 G1 NO NO NO NO LSCS I 4 N N N N TTN CPAP 3 DISCHARGE
326 POORNAM 49020 FCH 38 1.75 NO 30 G1 PIH NO NO NO LSCS I 4 N POS POS N SEPSIS CPAP 14 DISCHARGE
327 NARMATHA 49306 MCH 38 2.75 YES 23 G1 NO NO NO NO LN O 5 N N N N BA CPAP 8 DISCHARGE
328 BOMMU 49317 FCH 39 3.4 NO 20 G1 NO NO NO NO LSCS O 3 N N N N TTN HOOD 3 DISCHARGE
329 REKHA 49322 FCH 37 2.2 NO 23 G3A2 NO NO NO NO LN O 3 N N N N TTN HOOD 4 DISCHARGE
330 MANGALESWARI 49418 FCH 38 2.8 NO 29 G1 NO NO NO NO LSCS I 3 N N N N TTN HOOD 4 DISCHARGE
331 MALARSELVI 49546 MCH 40 3.25 NO 21 G1 NO NO NO YES LSCS I 2 N N N N TTN HOOD 2 DISCHARGE
332 SHANMUGAPRIYA 49608 MCH 39 3.1 YES 25 G2P1L1A1 ANEMIA NO NO NO LSCS O 6 ABN N N N O-CLE MV 2 DEATH
333 SYED ALI FATHIMA 49672 MCH 37 2.7 NO 27 G1 NO NO NO NO OF I 3 N N N N TTN HOOD 3 DISCHARGE
334 PANDIMEENA 49710 MCH 38 2.53 NO 22 G1 NO NO NO YES LSCS I 4 ABN N N N MAS CPAP 7 DISCHARGE
335 CHELLATHAI 49111 FCH 39 2.66 YES 17 G1 NO NO NO NO LSCS I 4 N N N N BA CPAP 2 DISCHARGE
336 NAZREEN 49612 FCH 39 3.25 YES 18 G1 NO NO NO NO LSCS I 4 N N N N BA CPAP 7 DISCHARGE
337 BAPITHA 49710 FCH 40 3.57 YES 18 G1 NO NO NO NO LSCS I 6 N N N N BA MV 2 DEATH
338 RANI 49757 FCH 40 3.42 YES 18 G1 NO NO NO NO LSCS I 7 N N N N BA MV 3 DEATH
339 POOJA 49715 FCH 40 3.56 YES 16 G1 NO NO NO NO LSCS I 6 N N N N BA MV 3 DEATH
340 RAJAMMAL 49816 MCH 37 2.06 YES 36 G3P1L1A1 GDM YES YES YES LSCS I 3 ABN N N N MAS HOOD 2 DISCHARGE
341 RAMAJOTHI 49927 MCH 38 4.15 YES 37 G3A2 UTI YES YES YES LSCS I 2 ABN N N N MAS HOOD 3 DISCHARGE
342 SWETHA 49718 MCH 38 3.03 NO 38 G3P2L2 ANEMIA NO NO YES LSCS I 4 ABN N N N MAS CPAP 11 DISCHARGE
343 SANGEETHA 49518 MCH 40 3 NO 19 G1 NO YES NO YES LSCS I 3 N N N N TTN HOOD 4 DISCHARGE
344 KARTHIGA 49893 FCH 38 4 NO 25 G1 NO YES NO NO LSCS I 3 N POS POS N SEPSIS HOOD 14 DISCHARGE
345 KARTHIGAI SELVI 50070 MCH 37 2.17 NO 25 G2P1L1 NO NO NO YES LSCS I 3 N N N N TTN HOOD 4 DISCHARGE
346 SHYAMALA DEVI 50121 FCH 38 2.5 NO 24 G2P1L1 NO NO NO NO LSCS I 5 N N N N TTN CPAP 5 DISCHARGE
347 BALAMURUGESWARI 50271 MCH 40 3.15 YES 23 G1 ANEMIA NO NO YES LN O 5 ABN N N N MAS CPAP 8 DISCHARGE
348 PANDEESWARI 50287 MCH 37 2.74 NO 21 G2P1L1 NO NO NO NO LN O 3 N N N N TTN HOOD 3 DISCHARGE
349 NAGALAKSHMI 50428 MCH 40 2.89 YES 21 G1 ANEMIA YES YES NO LSCS I 4 N N N N TTN CPAP 4 DISCHARGE
350 VANI 50340 FCH 38 3 NO 21 G1 ANEMIA YES YES NO LSCS I 3 N POS POS N SEPSIS HOOD 12 DISCHARGE
351 PRIYA 50852 FCH 38 1.79 YES 20 G3P1L1A1 NO NO NO YES LN I 6 ABN N N N BA MV <1 DEATH
352 NATHIYA 50589 MCH 37 2.5 NO 19 G1 NO NO NO NO OF I 3 N N N N TTN HOOD 3 DISCHARGE
353 SUMAIYA 50708 MCH 38 2.5 NO 24 G1 NO NO NO YES LN I 6 ABN N N PPHN MAS CPAP 10 DISCHARGE
354 MAHADEVI 50740 MCH 38 4 NO 26 G3P2L2 GDM NO NO NO LN I 4 ABN N N N RDS CPAP 21 DISCHARGE
355 KARPAGAM 50770 MCH 38 2.8 NO 20 G3P2L2 NO NO NO NO LN O 3 N N N N TTN HOOD 3 DISCHARGE
356 RAJALAKSHMI 50799 MCH 39 3.35 NO 23 G1 NO NO NO NO LN O 4 ABN N N N PN CPAP 12 DISCHARGE
357 VINITHA 50495 MCH 39 3.35 NO 19 G1 NO YES NO NO LSCS I 5 N POS POS N SEPSIS CPAP 14 DISCHARGE
358 LAVANYA 51294 MCH 38 3 NO 21 G1 NO NO NO NO LSCS I 3 N N N N TTN HOOD 3 DISCHARGE
359 SELVI 51339 FCH 38 3.09 NO 22 G1 ANEMIA NO NO YES LSCS I 3 N N N N TTN HOOD 3 DISCHARGE
360 DEIVAKANI 51403 MCH 37 2.42 NO 20 G1 ANEMIA NO NO NO LN I 3 N N N N TTN HOOD 3 DISCHARGE
361 SIVAMANI 51445 FCH 40 3.14 NO 24 G2P1L1 NO NO NO YES LN I 3 N N N N TTN HOOD 3 DISCHARGE
362 SURYAKALA 51423 MCH 40 3.23 NO 23 G2P1L1 ANEMIA NO NO YES LN O 5 ABN N N N MAS CPAP 7 DISCHARGE
363 KARPAGAM 51900 MCH 39 2.82 NO 20 G1 NO NO NO NO LN O 3 N N N N TTN HOOD 3 DISCHARGE
364 MUTHUMANI 51906 MCH 38 2.99 NO 19 G1 ANEMIA NO NO NO OF I 3 N N N N TTN HOOD 3 DISCHARGE
365 TAMILSELVI 51910 MCH 39 3 NO 26 G2A1 NO NO NO NO OF I 3 N N N N TTN HOOD 3 DISCHARGE
366 VIJAYAPANDI 51916 FCH 38 3 NO 28 G3P1L1A1 GDM NO NO NO LN I 3 N N N PDA CHD HOOD 4 DISCHARGE
367 NAGARANI 51947 FCH 39 2.71 NO 26 G1 NO NO NO NO LSCS O 5 ABN N N N PN CPAP 12 DISCHARGE
368 ABIRAMI 51952 FCH 38 3.71 NO 22 G1 NO YES NO NO LN I 3 N N N N TTN HOOD 4 DISCHARGE
369 VELANKANNI 51984 MCH 37 1.81 NO 19 G1 PIH NO NO NO LSCS I 3 N N N N TTN HOOD 4 DISCHARGE
370 ILAKKIYA 51546 MCH 39 3 NO 24 G2P1L1 ANEMIA NO NO NO LN I 3 N N N ASD CHD HOOD 4 DISCHARGE
371 JEYABHARATHI 52129 MCH 39 2.9 YES 30 G2P1L1 NO NO NO NO LN I 6 N N N N BA CPAP 10 DISCHARGE
372 MEENA 52267 FCH 38 2.86 YES 21 G1 ANEMIA NO YES NO LN I 4 N N N N BA CPAP 8 DISCHARGE
373 VASUKI 52325 FCH 38 3.84 YES 28 G3P1L1A1 APH NO NO NO LN I 6 N N N N BA MV 1 DEATH
374 BHAKIYAM 52561 MCH 37 2.5 NO 27 G1 NO NO NO NO OF I 3 N N N N TTN HOOD 3 DISCHARGE
375 KALYANI 52679 FCH 40 3.5 YES 29 G1 NO NO NO YES LSCS O 6 ABN N N N MAS MV 2 DEATH
376 CHITRA 52907 MCH 40 2.5 NO 27 G1 NO NO NO YES LN I 3 N N N N TTN HOOD 4 DISCHARGE
377 SAJITHA PARVIN 52897 FCH 37 4 NO 27 G1 GDM NO NO NO LSCS I 3 N N N PDA CHD HOOD 4 DISCHARGE
378 PRIYA 52964 MCH 37 2.06 NO 27 G1 A YES NO NO LN I 4 ABN N N N PN CPAP 10 DISCHARGE
379 KARTHIGA 52991 FCH 39 2.8 YES 18 G1 NO NO YES YES LSCS O 5 N N N N BA CPAP 11 DISCHARGE
380 SUGANTHI 52986 MCH 39 2.83 YES 20 G1 NO NO NO NO LSCS I 7 N N N N BA MV 22 DISCHARGE
381 PADMA 53001 MCH 40 2.94 NO 24 G1 NO NO NO NO LN I 3 N N N N TTN HOOD 3 DISCHARGE
382 DURGADEVI 53109 MCH 40 3.28 YES 22 G2P1L1 NO NO NO NO LN O 5 N N N N BA CPAP 12 DISCHARGE
383 RAJALAKSHMI 53130 MCH 39 3.45 NO 27 G3P1L1A1 NO NO NO NO LN I 3 N N N N TTN HOOD 3 DISCHARGE
384 INDUMATHI 53158 MCH 40 3.14 YES 21 G2A1 NO NO NO NO LN I 4 N N N N BA CPAP 10 DISCHARGE
385 MANIMEGALAI 53173 MCH 40 3.16 YES 21 G1 NO NO NO YES LN I 5 ABN N N N BA CPAP 12 DISCHARGE
386 NAGARANI 53221 FCH 37 2.5 NO 29 G3P1L1A1 ANEMIA NO NO NO LSCS I 2 N N N N TTN HOOD 3 DISCHARGE
387 SIVARANJANI 53301 MCH 39 3.1 NO 21 G1 NO NO YES NO LSCS I 3 N N N N TTN HOOD 3 DISCHARGE
388 VELMANI 53407 FCH 38 2.55 YES 22 G1 HYPOTY NO NO NO LSCS I 5 N N N N BA CPAP 9 DISCHARGE
389 VIMALA 53482 MCH 40 3.375 YES 22 G1 NO NO YES NO LSCS I 4 N N N N BA CPAP 10 DISCHARGE
390 SHEELADEVI 44014 FCH 40 2.5 NO 21 G1 PIH NO NO YES LN I 3 N N N N TTN HOOD 4 DISCHARGE
391 JEYAKODI 44064 MCH 37 2.4 NO 23 G2P1L1 NO NO NO NO LSCS I 4 N N N N TTN CPAP 4 DISCHARGE
392 SUGUNA 44219 FCH 37 2.68 NO 19 G3P2L2 PIH NO NO NO LSCS I 3 N N N N TTN HOOD 4 DISCHARGE
393 MAHALAKSHMI 44256 FCH 39 2.49 YES 20 G1 NO NO NO NO OF I 5 N N N N BA CPAP 10 DISCHARGE
394 MUTHEESWARI 44300 MCH 40 3.35 NO 20 G1 NO NO NO NO LSCS I 4 N N N PPHN MAS CPAP 7 DISCHARGE
395 NANDHINI 44417 FCH 38 2.13 YES 23 G1 NO NO NO NO LN O 6 N N N N BA CPAP 11 DISCHARGE
396 PARVIN 44442 MCH 39 4 NO 22 G1 PIH NO NO NO LSCS I 3 N N N N TTN HOOD 4 DISCHARGE
397 JEYALAKSHMI 44520 FCH 39 2.75 NO 26 G2A1 NO YES NO NO LN I 3 N N N N TTN HOOD 3 DISCHARGE
398 VEERASELVI 44598 MCH 39 3.5 NO 22 G2P1L1 NO NO NO NO LSCS I 3 N N N PDA CHD HOOD 3 DISCHARGE
399 KAVIYA 45009 FCH 38 3 NO 25 G3A2 NO NO NO NO LN I 3 N N N N TTN HOOD 4 DISCHARGE
400 HEMAPRIYA 45051 FCH 38 2.5 NO 25 G1 ANEMIA NO NO NO LSCS I 3 N N N PDA CHD HOOD 3 DISCHARGE
401 PARAMESWARI 45055 MCH 40 3.5 NO 23 G1 NO NO NO NO LSCS I 3 N N N N TTN HOOD 4 DISCHARGE
402 SANDHYA 45110 MCH 39 2.64 YES 20 G1 NO NO YES NO LN I 3 N N N N BA CPAP 8 DISCHARGE
403 PETCHI 45210 MCH 38 2.7 YES 21 G1 ANEMIA NO NO NO LN O 6 N N N N BA CPAP 10 DISCHARGE
404 KALA 45188 FCH 38 2.75 NO 33 G5P2L2A2 NO NO NO NO LSCS I 3 N N N N TTN HOOD 4 DISCHARGE
405 JAMUNA 45287 MCH 39 3 YES 26 G1 ANEMIA NO YES NO LSCS I 5 N N N N BA CPAP 8 DISCHARGE
406 SURYAKALA 45543 MCH 37 1.7 NO 23 G1 PIH NO NO NO LN I 2 N N N N TTN HOOD 7 DISCHARGE
407 SHYLAJA 45833 FCH 38 2.25 NO 25 G1 NO YES NO NO LN I 3 N POS POS N SEPSIS HOOD 14 DISCHARGE
408 SATHYAPRIYA 45884 MCH 39 2.5 NO 21 G1 NO NO NO NO LN I 3 N N N N TTN HOOD 4 DISCHARGE
409 LAKSHMIDEVI 46010 MCH 38 2.55 YES 24 G1 NO NO NO NO LN I 4 N N N N BA CPAP 8 DISCHARGE
410 NITHYA 46029 MCH 40 3.18 YES 18 G1 PIH NO NO NO LN I 5 N N N N BA CPAP 11 DISCHARGE
411 CHINNAKALI 46110 MCH 38 3 NO 24 G2P1L1 GDM NO NO NO LN I 3 ABN N N PDA CHD HOOD 10 DISCHARGE
412 SANGEETHA 46229 MCH 38 2.21 NO 22 G3P1L1A1 PIH NO NO NO LN O 3 N POS POS N SEPSIS HOOD 14 DISCHARGE
413 REVATHY 46201 FCH 39 3.5 NO 19 G1 NO NO NO NO LN I 3 N N N N TTN HOOD 5 DISCHARGE
414 MURUGESWARI 46241 FCH 37 2 YES 25 G1 NO NO NO NO LSCS I 3 N N N N TTN HOOD 3 DISCHARGE
415 SEETHALAKSHMI 46276 MCH 37 1.5 NO 22 G2P1L1 PIH NO NO NO LSCS I 3 N POS POS N SEPSIS HOOD 14 DISCHARGE
416 CHINNAPONNU 46277 MCH 37 1.85 NO 30 G4A3 ANEMIA NO NO NO LSCS I 3 N N N N TTN HOOD 4 DISCHARGE
417 MUTHUKOODAMMAL 46455 MCH 40 3.5 YES 27 G1 NO NO YES NO LN O 6 N N N N BA MV 1 DEATH
418 KALAIYARASI 46457 MCH 40 3.22 YES 24 G3A2 NO NO NO NO LSCS I 5 N N N N BA MV 2 DEATH
419 RAJESWARI 46697 MCH 39 3 NO 30 G1 NO NO NO NO LSCS I 3 N N N N TTN HOOD 3 DISCHARGE
420 MUTHULAKSHMI 46691 MCH 37 2.3 NO 23 G1 NO YES NO NO LSCS I 3 N POS POS N SEPSIS CPAP 14 DISCHARGE
421 GOWSALYA 46844 MCH 40 2.3 NO 24 G1 NO NO NO YES LSCS O 4 ABN N N N MAS CPAP 8 DISCHARGE
422 SABIKA 46898 MCH 39 3.67 NO 23 G1 NO NO NO NO LSCS O 3 N N N PDA O-APERT HOOD 3 DISCHARGE
423 LAVANYA 46890 FCH 37 2.25 NO 21 G1 ANEMIA NO NO NO LN I 2 N N N N TTN HOOD 3 DISCHARGE
424 ULAGESWARI 46908 MCH 37 2.66 YES 20 G1 NO NO NO NO LSCS I 5 N N N N BA MV 1 DEATH
425 DIVYA 46905 MCH 38 3 NO 23 G1 HYPOTY NO NO NO LSCS I 3 N N N N TTN HOOD 3 DISCHARGE
426 TAMILARASI 46907 MCH 38 2.8 NO 30 G3A2 NO NO NO NO LSCS I 3 N N N PDA CHD HOOD 3 DISCHARGE
427 KALAIYARASI 46457 MCH 40 3.22 YES 19 G1 NO NO NO YES LSCS I 5 N N N N BA MV 2 DEATH
428 THANGAMMAL 47015 MCH 37 1.9 NO 24 G3P2L1 ANEMIA YES NO NO LN I 5 N POS POS N SEPSIS CPAP 14 DISCHARGE
429 RANJITHAM 47231 FCH 40 3.27 NO 25 G2P1L1 NO NO NO YES LN O 3 N N N N MAS HOOD 3 DISCHARGE
430 VIDHYA 47332 MCH 38 2.66 NO 15 G1 NO NO NO NO LSCS I 2 N N N N TTN HOOD 2 DISCHARGE
431 KALAIRASI 47239 MCH 38 3.25 NO 18 G1 NO NO NO NO LSCS I 3 N N N N TTN HOOD 3 DISCHARGE
432 KAVITHA 47234 MCH 38 3.57 NO 18 G1 NO NO NO NO LSCS I 2 N N N N TTN HOOD 2 DISCHARGE
433 SYED ALI FATHIMA 47232 MCH 38 3.7 NO 18 G1 NO NO NO NO LSCS I 3 N N N N TTN HOOD 3 DISCHARGE
434 PARVEEN BANU 47236 MCH 39 3 NO 18 G1 NO NO NO NO LSCS I 3 N N N N TTN HOOD 3 DISCHARGE
435 JOHN THERESA 47357 MCH 39 2.9 NO 18 G1 NO NO NO NO LSCS I 2 N N N N TTN HOOD 2 DISCHARGE
436 JANSI RANI 47348 FCH 39 2.86 NO 18 G1 NO NO NO NO LSCS I 3 N N N N TTN HOOD 3 DISCHARGE
437 JOTHI 47239 FCH 39 3.84 NO 17 G1 NO NO NO NO LSCS I 2 N N N N TTN HOOD 2 DISCHARGE
438 LAKSHMI 47356 MCH 38 3 NO 19 G1 NO NO NO NO LN O 3 N N N PDA CHD HOOD 5 DISCHARGE
439 PANCHVARNAM 47375 FCH 37 1.77 NO 25 G3P1L1A1 NO NO NO NO LSCS I 3 N N N N TTN HOOD 4 DISCHARGE
440 MURUGESWARI 47387 MCH 40 3.36 NO 25 G2P1L1 NO NO NO YES LSCS I 4 N N N N MAS CPAP 7 DISCHARGE
441 KALAMANI 47671 FCH 38 2.75 NO 24 G2P1L1 NO NO NO NO OF I 2 N N N N TTN HOOD 4 DISCHARGE
442 NANDHINI 47699 MCH 38 3 NO 20 G1 NO NO NO NO LN I 3 N N N ASD CHD HOOD 4 DISCHARGE
443 SUGANTHA ROSE 47906 MCH 40 3.8 NO 22 G1 PIH NO NO NO LSCS I 3 N N N N TTN HOOD 3 DISCHARGE
444 BHUVANESWARI 47981 MCH 37 2.735 NO 19 G1 ANEMIA NO NO NO LN O 3 N N N N TTN HOOD 4 DISCHARGE
445 SARANYA 30560 MCH 40 2 NO 24 G2P1L1 NO NO NO NO LN O 4 N N N N TTN HOOD 3 DISCHARGE
446 NAGALAKSHMI 30582 MCH 38 3 NO 21 G1 NO NO NO NO LN I 3 ABN N N N TTN HOOD 4 DISCHARGE
447 NAGAJOTHI 30714 FCH 40 2.92 YES 22 G1 NO YES NO NO LN I 5 N N N N BA CPAP 8 DISCHARGE
448 JEYALAKSHMI 30972 MCH 38 2.5 NO 19 G1 NO NO NO YES LN I 3 N N N N TTN HOOD 3 DISCHARGE
449 DEVI 30780 MCH 38 3 YES 25 G1 PIH NO NO NO LN I 5 N N N N BA CPAP 10 DISCHARGE
450 PANDIYAMMAL 30823 FCH 38 2.955 YES 20 G2A1 NO NO NO NO LN I 6 N N N N BA MV 13 DEATH
451 MUTHUKILI 31133 MCH 40 3 NO 30 G3P2L2 NO NO NO YES LN O 5 ABN N N N MAS CPAP 8 DISCHARGE
452 SUGUNADEVI 31140 MCH 38 3.2 NO 25 G2P1L1 PIH NO NO YES LSCS I 3 N N N N TTN HOOD 3 DISCHARGE
453 MOOKAMMAL 31300 FCH 38 2.625 NO 23 G2P1L1 NO NO NO NO LSCS I 3 N N N PDA CHD HOOD 4 DISCHARGE
454 SIBORAL 31360 MCH 37 2.62 YES 29 G4P2L2A1 NO NO NO NO LN I 3 N N N N BA HOOD 7 DISCHARGE
455 VASANTHA 31435 FCH 38 3.05 NO 21 G1 PIH NO NO NO LSCS I 3 N N N N TTN HOOD 4 DISCHARGE
456 SUBBULAKSHMI 31516 MCH 37 2.6 NO 25 G2P1L1 NO YES NO NO LSCS I 3 N N N N TTN HOOD 3 DISCHARGE
457 PRIYADHARSHINI 31547 FCH 40 3.4 NO 22 G1 NO NO YES YES LSCS I 3 ABN N N N MAS HOOD 3 DISCHARGE
458 PANDISELVI 31585 MCH 38 2.51 NO 20 G2P1L1 NO NO NO NO LN O 3 N N N N TTN HOOD 3 DISCHARGE
459 MUTHUMANI 31672 MCH 38 3.5 NO 26 G1 NO NO NO NO OF I 3 N N N N TTN HOOD 4 DISCHARGE
460 NAGAJOTHI 31762 MCH 38 3.03 YES 27 G2P1L1 NO NO NO NO LN O 5 N N N N BA CPAP 8 DISCHARGE
461 NEETHIVANI 32032 MCH 40 3.25 YES 20 G1 PIH NO NO NO LN I 3 N N N N BA HOOD 4 DISCHARGE
462 DIVYA 32104 FCH 37 2.53 NO 22 G4A3 NO NO NO NO LN O 3 N N N N TTN HOOD 3 DISCHARGE
463 SAJITHA BANU 32100 MCH 38 3.85 NO 24 G2P1L1 NO NO NO NO LSCS I 3 N N N ASD CHD HOOD 7 DISCHARGE
464 NAGAMMAL 32278 MCH 39 2.75 NO 22 G2A1 NO YES YES NO LN I 3 N POS POS N SEPSIS HOOD 14 DISCHARGE
465 PANDISELVI 32281 MCH 39 3.2 YES 23 G2P1L1 NO NO NO NO LN O 5 N N N N BA CPAP 9 DISCHARGE
466 SUNITHA 32446 MCH 40 3.85 YES 25 G2P1L1 NO NO NO YES LSCS O 7 ABN N N PPHN MAS MV 3 DEATH
467 PREMA 32810 FCH 40 3.25 NO 30 G3P1L1A2 NO NO NO YES LSCS I 3 ABN N N N MAS HOOD 4 DISCHARGE
468 PRIYA 32860 FCH 40 3.5 YES 23 G1 NO NO NO NO LSCS I 5 N N N N BA CPAP 8 DISCHARGE
469 SUGAPRIYA 32991 FCH 38 3.2 NO 26 G3P2L2 NO NO NO NO LN I 5 N N N PDA CHD CPAP 5 DISCHARGE
470 ASWINI 33024 MCH 38 2.9 NO 21 G1 PIH NO NO NO LSCS I 3 N N N N TTN HOOD 3 DISCHARGE
471 NAVANYA 33228 MCH 39 3 NO 20 G2P1L1 NO NO NO NO LSCS I 3 N N N N TTN HOOD 4 DISCHARGE
472 MURUGESWARI 33328 MCH 39 3.7 YES 25 G4P1L1A2 NO NO NO NO LN I 6 N N N N BA CPAP 14 DISCHARGE
473 GOWSALYA 33378 MCH 38 2.75 NO 24 G1 NO NO NO YES LSCS I 3 ABN N N N MAS HOOD 5 DISCHARGE
474 SEETHALAKSHMI 33407 FCH 38 2.3 YES 29 G2P1L1 NO NO NO NO LN O 3 N N N N BA HOOD 6 DISCHARGE
475 ANJALI 33511 FCH 38 1.9 NO 26 G1 NO NO YES NO LSCS I 3 ABN N N N SEPSIS HOOD 12 DISCHARGE
476 PANGAJAM 33645 MCH 39 2.3 NO 22 G1 NO NO NO NO LSCS O 3 N N N N TTN HOOD 3 DISCHARGE
477 JEYAPRIYA 33672 FCH 40 2.68 YES 19 G1 NO NO NO NO LSCS I 5 N N N N BA CPAP 12 DISCHARGE
478 ANUSHYA 33671 FCH 38 2.9 NO 19 G1 NO NO NO NO LSCS I 3 N N N N TTN HOOD 3 DISCHARGE
479 INDIRA 33785 FCH 40 3 NO 23 G2P1L1 NO NO NO NO LN I 3 ABN N N VSD CHD HOOD 4 DISCHARGE
480 CHITRA 33884 FCH 38 2.34 NO 20 G1 NO NO NO NO LN O 3 N N N N TTN HOOD 3 DISCHARGE
481 DHANALAKSHMI 33856 MCH 38 1.86 NO 29 G2P1L1 GDM NO NO NO LSCS I 2 ABN N N ASD CHD HOOD 4 DISCHARGE
482 ARTHISELVI 33893 MCH 38 2.72 NO 20 G1 PIH NO NO NO LSCS I 3 ABN N N N TTN HOOD 3 DISCHARGE
483 MAHALAKSHMI 33923 MCH 38 2.2 NO 19 G1 PIH NO NO NO LN I 3 N N N N TTN HOOD 3 DISCHARGE
484 KAMATCHI 33942 MCH 37 2.25 NO 23 G1 NO YES YES NO LN I 3 N POS POS N SEPSIS HOOD 14 DISCHARGE
485 SUDHA 34086 MCH 37 2.7 YES 23 G1 NO NO NO NO LN O 7 N N N N BA MV 9 DEATH
486 SELVI 34103 MCH 39 3 NO 25 G1 NO YES YES NO LN I 4 N POS POS N SEPSIS HOOD 12 DISCHARGE
487 NAGARANI 34311 MCH 39 2.91 NO 28 G3P2L2 NO YES NO NO LSCS O 4 N POS POS N SEPSIS HOOD 12 DISCHARGE
488 KARTHIGA 34349 MCH 39 3.15 NO 24 G2A1 NO NO NO NO LSCS I 3 N N N N TTN HOOD 3 DISCHARGE
489 MALATHI 34816 MCH 40 3.25 NO 20 G1 NO YES YES NO LSCS I 3 N N N N TTN HOOD 3 DISCHARGE
490 KARTHIGA 34832 MCH 38 3 NO 22 G3P1A1D1 NO NO NO NO LSCS I 2 N N N N TTN HOOD 2 DISCHARGE
491 TAMIL PARVEEN 34837 FCH 37 2.75 NO 20 G1 NO NO NO NO LN I 3 N N N N TTN HOOD 5 DISCHARGE
492 MANI MUTHU 34944 FCH 40 3.02 NO 24 G1 NO NO NO YES LN I 5 ABN N N N MAS CPAP 6 DISCHARGE
493 SAROJA 35006 FCH 38 2.6 NO 29 G2P1D1 NO NO NO NO OF I 3 N N N N TTN HOOD 4 DISCHARGE
494 GAYATHRI 35022 FCH 39 3.75 NO 28 G2A1 NO YES NO NO LN O 3 N N N N TTN HOOD 4 DISCHARGE
495 RAAGINI 35098 MCH 37 2.91 YES 20 G1 NO NO YES NO LN O 5 N N N N BA CPAP 7 DISCHARGE
496 MUTHARASAAHY 35083 FCH 39 3.3 YES 28 G3P1L1A1 NO NO YES NO LSCS I 4 N POS POS N SEPSIS CPAP 12 DISCHARGE
497 GAYATHRI 35102 MCH 37 2.7 NO 26 G2P1L1 NO YES YES NO LN I 4 N POS POS N SEPSIS CPAP 14 DISCHARGE
498 PANDEESWARI 35183 MCH 40 2.5 YES 27 G1 PIH YES NO YES LN I 6 ABN N N N BA MV <1 DEATH
499 LATHA 35222 FCH 37 2.09 NO 23 G2P1L1 NO NO NO NO LSCS O 4 ABN N N PDA CHD CPAP 6 DISCHARGE
500 NIRANJANA DEVI 35273 FCH 37 2.56 YES 25 G1 NO NO NO YES LSCS O 7 ABN N N N MAS MV 14 DEATH
501 PANDEESWARI 35278 MCH 39 2.35 NO 22 G5P2L2A2 NO NO NO NO LSCS I 4 N N N N TTN CPAP 4 DISCHARGE
502 DHANALAKSHMI 35361 MCH 37 2.65 NO 21 G1 NO NO NO NO LN O 3 N N N N TTN HOOD 4 DISCHARGE
503 POUNTHAI 35363 FCH 40 3.26 NO 21 G1 NO NO NO NO LN I 3 N N N N TTN HOOD 3 DISCHARGE
504 KOWSALYA DEVI 35366 FCH 37 2.72 NO 23 G1 NO NO NO NO LSCS O 4 N N N N TTN CPAP 7 DISCHARGE
505 AMARAVATHI 35464 MCH 37 2.6 NO 28 G5P2L2A2 NO NO NO NO LSCS I 4 N N N N TTN CPAP 6 DISCHARGE
506 CHITRA 35491 MCH 37 2.7 NO 26 G2P1L1 NO NO NO YES LN O 5 ABN N N N MAS CPAP 7 DISCHARGE
507 KAVITHA 35671 FCH 37 2.51 NO 22 G1 NO NO NO YES LN O 3 N N N N TTN HOOD 3 DISCHARGE
508 MUTHUMALAR 36115 MCH 37 2.6 NO 24 G4P2L1A1 NO NO NO NO LSCS I 4 N N N N TTN HOOD 4 DISCHARGE
509 ISWARIYA 36200 MCH 37 1.98 NO 21 G2P1L1 NO NO NO NO LN I 2 N N N N TTN HOOD 4 DISCHARGE
510 VIJAYASANTHI 36219 FCH 39 2.7 NO 22 G2P1L1 NO NO NO NO LSCS I 3 N N N N TTN HOOD 4 DISCHARGE
511 JEYANTHI 36363 MCH 39 3.2 NO 33 G2P1L1 NO NO NO NO LSCS I 5 N POS POS N SEPSIS CPAP 14 DISCHARGE
512 SARASWATHI 36458 FCH 39 2.9 NO 25 G1 NO NO NO YES LN I 3 N N N N TTN HOOD 3 DISCHARGE
513 CHITRA 36603 MCH 40 3.4 YES 24 G3P1L1D1 NO NO NO NO LN O 6 N N N N BA CPAP 10 DISCHARGE
514 MARIAMMAL 36632 FCH 37 2.4 NO 24 G2P1L1 NO NO NO NO LN O 3 N N N N TTN HOOD 3 DISCHARGE
515 MALARVIZHI 36972 MCH 39 3 NO 21 G2P1L1 ANEMIA NO NO YES LSCS I 4 ABN N N N MAS CPAP 7 DISCHARGE
516 SUBATHRA 37173 MCH 39 3.15 NO 24 G2P1L1 PIH NO NO NO LSCS I 4 N N N N TTN CPAP 4 DISCHARGE
517 KANAKKAL 37274 MCH 39 3.08 YES 24 G3P2L1D1 NO NO NO NO LN O 6 N N N N BA CPAP 12 DISCHARGE
518 RANJITHA 37345 MCH 38 2.7 NO 20 G1 NO NO NO YES LSCS I 6 ABN N N N MAS MV 14 DISCHARGE
519 KANMANI 37362 MCH 38 3.2 NO 25 G2P1L1 HYPOTY NO NO NO LSCS I 3 N N N N TTN HOOD 5 DISCHARGE
520 NIRAIMATHI 37477 MCH 38 3.28 NO 30 G22P1L1 GDM NO NO NO LSCS O 5 N N N ASD CHD CPAP 7 DISCHARGE
521 MAHALAKSHMI 37536 MCH 37 2.435 YES 36 G5P2L2 GDM YES YES YES LSCS I 2 ABN N N N TTN HOOD 2 DISCHARGE
522 MALA 37467 MCH 37 2.225 NO 37 G5P1L1A2 GDM YES YES NO LSCS I 3 ABN N N N TTN HOOD 3 DISCHARGE
523 MALATHI 37678 MCH 37 2.7 NO 38 G5A4 ANEMIA NO NO NO LSCS I 3 ABN N N N TTN HOOD 3 DISCHARGE
524 MARIAMMAL 37477 MCH 37 2.95 NO 40 G5P3L3A1 NO NO NO NO LSCS I 2 N N N N TTN HOOD 2 DISCHARGE
525 PANCHAVARNAM 37677 MCH 38 3.4 NO 44 G5P1L1A2 NO NO NO NO LSCS I 3 N N N N TTN HOOD 3 DISCHARGE
526 PANDIYAMMAL 37477 MCH 38 3.42 NO 17 G1 NO NO NO NO LSCS I 2 N N N N TTN HOOD 2 DISCHARGE
527 PUSHPA 378037 MCH 38 3.56 NO 16 G1 NO NO NO NO LSCS I 3 N N N N TTN HOOD 3 DISCHARGE
528 GEETHA 37777 MCH 38 2.65 NO 18 G1 NO NO NO NO LSCS I 3 N N N N TTN HOOD 3 DISCHARGE
529 RANJITHA 37522 MCH 40 3.47 YES 25 G3P1L1A1 NO NO NO YES LN O 5 ABN N N N MAS MV <1 DEATH
530 NAVANEETHA 37525 MCH 38 2.25 NO 19 G1 NO NO NO NO LN O 5 ABN POS POS N SEPSIS MV 3 DEATH
531 VALARMATHI 37513 MCH 37 3 NO 28 G1 NO NO NO NO LSCS I 3 N N N N TTN HOOD 2 DISCHARGE
532 RAJESWARI 37659 FCH 40 3.5 NO 21 G1 NO YES NO NO LN I 5 N N N N TTN CPAP 4 DISCHARGE
533 ANITHA 37777 MCH 40 3.23 YES 25 G2P1L1 NO YES YES YES LN I 6 ABN N N N BA MV 12 DISCHARGE
534 ANBUKANI 37859 FCH 37 2.5 NO 25 G2A1 GDM NO NO NO LN I 4 N N N PDA CHD CPAP 4 DISCHARGE
535 RADHIKA 37929 FCH 38 3.48 YES 26 G2P1L1 NO NO NO NO LN O 6 N N N N BA MV 3 DEATH
536 SELVARATHI 38474 FCH 38 3.2 YES 30 G3P1L1A1 PIH NO NO NO LN I 6 N N N N BA MV 2 DEATH
537 PRIYA 35603 MCH 38 2.79 NO 28 G3P2L2 NO NO NO NO LN I 4 N N N ASD CHD CPAP 6 DISCHARGE
538 VENNILA 38764 FCH 38 2.25 NO 23 G2P1L1 NO NO NO NO LSCS I 5 N N N VSD CHD CPAP 8 DISCHARGE
539 BARGAVI 39003 MCH 38 2.56 NO 19 G1 PIH YES YES NO LN I 5 ABN N N N BA MV 14 DEATH
540 SUGANTHI 39345 MCH 38 2.8 NO 25 G1 NO NO NO NO LSCS I 3 N N N N TTN HOOD 4 DISCHARGE
541 PAPATHI 39439 MCH 38 3 NO 22 G1 GDM NO NO NO LSCS I 3 N N N ASD CHD HOOD 5 DISCHARGE
542 SARANYA 39463 MCH 38 4 NO 27 G3P1L1A1 NO NO NO NO LN I 5 N N N PDA CHD CPAP 5 DISCHARGE
543 NATCHATHIRAM 39557 MCH 39 2.94 YES 27 G2P1L1 NO NO NO NO LN I 7 N N N N BA MV 15 DISCHARGE
544 CHANDRALEKHA 39617 MCH 38 3.375 NO 25 G2P1L1 NO NO NO NO LSCS I 3 N N N N TTN HOOD 4 DISCHARGE
545 AATHIKA 39704 MCH 39 3.48 YES 19 G1 NO NO NO NO LN O 5 N N N PDA CHD CPAP 6 DISCHARGE
546 SOUNTHIRADEVI 39728 MCH 38 2.2 NO 23 G3P2L2 NO YES YES NO LSCS I 5 N POS POS N SEPSIS CPAP 14 DISCHARGE
547 RANJITHA 39793 MCH 40 2.5 NO 20 G1 NO NO NO NO LN I 4 N N N N TTN CPAP 4 DISCHARGE
548 HEMA 40005 MCH 39 3.58 YES 26 G2P1L1 NO NO NO NO LN O 8 N N N N BA MV 10 DEATH
549 SEETHALAKSHMI 40153 FCH 38 3.3 NO 29 G2P1L1 NO NO NO NO LN O 4 N N N N TTN CPAP 5 DISCHARGE
550 VINITHA 40119 MCH 38 2.2 NO 21 G1 NO NO NO NO LSCS O 4 N N N ASD CHD CPAP 7 DISCHARGE
551 MAHESWARI 40244 FCH 38 2.4 NO 23 G5P1L1A3 NO NO NO NO LSCS I 3 N N N N TTN HOOD 4 DISCHARGE
552 KANCHANA 40145 MCH 38 2.64 NO 21 G1 NO NO NO NO LSCS I 3 N N N N TTN HOOD 4 DISCHARGE
553 ARUDAYAMMAL 22954 MCH 38 2.75 NO 36 G2P1L1 GDM NO NO NO LSCS I 3 N N N N O-CA HOOD 10 DISCHARGE
554 PANDILAKSHMI 23222 MCH 39 3.35 NO 21 G3P2L2 NO NO NO YES LN O 3 ABN N N N MAS HOOD 2 DISCHARGE
555 SHAKTHEESWARI 23266 FCH 38 2.5 NO 20 G2A1 NO NO NO YES LSCS I 3 N N N N TTN HOOD 5 DISCHARGE
556 PONNUTHAI 23324 MCH 38 2.6 NO 30 G2P1L1 NO NO NO NO LSCS I 3 N N N ASH CHD HOOD 5 DISCHARGE
557 MAHESWARI 23359 MCH 38 3.5 NO 20 G1 HYPOTY NO NO NO LSCS I 2 N N N N TTN HOOD 2 DISCHARGE
558 GANDHIMATHI 23426 FCH 39 3 NO 24 G3P1L1A1 NO NO NO NO LN I 3 N N N N TTN HOOD 4 DISCHARGE
559 MAYARAM SANTHYA 23553 MCH 39 3.25 YES 18 G1 NO NO NO NO LSCS I 4 N N N N BA CPAP 6 DISCHARGE
560 MAHALAKSHMI 23622 MCH 38 2.6 NO 27 G2P1L1 NO NO NO NO LN O 5 ABN N N TGA CHD CPAP <1 DEATH
561 RAMALAKSHMI 24733 FCH 40 3 NO 20 G1 PIH NO NO NO LSCS I 3 N N N N TTN HOOD 2 DISCHARGE
562 ILAKKIYA 24825 MCH 39 3.38 YES 27 G3P2L1A1 NO NO NO NO LN O 4 N N N N BA CPAP 10 DISCHARGE
563 BUVANESWARI 24906 MCH 40 3.25 NO 26 G2P1L1 NO NO NO YES LN I 3 N N N N TTN HOOD 2 DISCHARGE
564 ABARNA 25077 MCH 39 3.5 YES 19 G1 NO NO YES YES LN O 4 N N N N BA CPAP 10 DISCHARGE
565 SELVALAKSHMI 25245 MCH 39 3.15 NO 21 G1 NO NO NO YES LSCS I 3 N N N N TTN HOOD 5 DISCHARGE
566 PANDEESWARI 25376 MCH 37 2.78 YES 25 G4P1L1A1D1ANEMIA NO NO NO LN O 4 N N N N BA CPAP 10 DISCHARGE
567 UMA MAHESWARI 25456 MCH 39 4.02 NO 26 G1 ANEMIA NO YES NO LSCS I 3 N N N N TTN HOOD 4 DISCHARGE
568 NAGAJOTHI 25505 MCH 40 3.04 YES 19 G1 ANEMIA NO NO NO LN O 4 N N N N BA CPAP 12 DISCHARGE
569 PAPPATHIYAMMAL 25802 FCH 37 3.2 NO 26 G1 GDM NO NO NO LSCS I 3 N N N PDA CHD HOOD 5 DISCHARGE
570 PRIYA 25989 MCH 39 2.75 YES 24 G1 NO NO YES NO LN I 6 N N N N BA MV 5 DEATH
571 KALAISELVI 26340 MCH 39 3.4 NO 26 G1 NO NO NO NO LSCS O 5 ABN N N N O-NIH MV 5 DEATH
572 ANITHA 26375 MCH 40 3.42 NO 25 G1 PIH NO NO YES LSCS O 4 ABN N N PPHN MAS CPAP 10 DISCHARGE
573 PRIYA 26373 MCH 38 3.76 NO 23 G1 NO NO YES NO LSCS I 3 N N N N TTN HOOD 3 DISCHARGE
574 CHITRA 26380 MCH 39 2.75 NO 20 G1 ANEMIA NO NO NO LN I 2 N N N N TTN HOOD 3 DISCHARGE
575 BHAGYAVATHY 26691 MCH 40 3 NO 20 G1 NO YES YES YES LSCS I 2 N N N N TTN HOOD 5 DISCHARGE
576 NANDHINI 26875 MCH 38 2.7 NO 22 G1 ANEMIA NO NO YES LN O 4 N POS POS N SEPSIS CPAP 14 DISCHARGE
577 HEMALATHA 27054 FCH 39 2.67 YES 19 G1 ANEMIA YES YES NO LN I 3 N POS POS N SEPSIS CPAP 14 DISCHARGE
578 SIVALAKSHMI 27112 MCH 38 2.75 YES 22 G2P1L1 NO NO NO NO LSCS I 6 N N N N BA CPAP 12 DEATH
579 SHANMUGAPRIYA 27097 FCH 37 3.55 NO 22 G3P1L1A1 ANEMIA NO NO NO LSCS I 2 N POS POS N SEPSIS HOOD 14 DISCHARGE
580 MALATHI 27139 MCH 38 2.19 NO 21 G1 NO NO NO NO LN I 4 N N N ASD CHD CPAP <1 DISCHARGE
581 KANIPRIYA 27869 MCH 38 1.9 YES 25 G2P1L1 PIH NO NO YES LSCS O 5 ABN N N PPHN MAS MV 2 DEATH
582 VENNILA 27875 FCH 40 2.3 YES 24 G1 ANEMIA NO NO NO LN O 6 N N N N BA MV 4 DEATH
583 SUGANTHI 28002 MCH 38 3 YES 26 G1 NO NO NO NO LN O 4 N POS POS N SEPSIS CPAP 14 DISCHARGE
584 NAVEENA 28011 MCH 39 3.7 NO 27 G4P1L1A2 GDM NO NO NO LSCS I 4 ABN N N PDA CHD CPAP 6 DISCHARGE
585 MUTHULAKSHMI 28082 FCH 38 1.5 NO 26 G3P1L1A1 APH NO NO NO LN I 5 N N N VSD CHD MV 12 DISCHARGE
586 GEETHA 28134 MCH 38 3.4 YES 26 G4P1L1A1D1PIH NO NO YES LN I 6 ABN N N ASD CHD MV 10 DISCHARGE
587 KATHIRIAMMAL 28176 MCH 39 2.5 NO 35 G3P2L2 NO NO NO NO LN I 3 N N N N TTN HOOD 2 DISCHARGE
588 SUBBULAKSHMI 28459 MCH 37 2.71 NO 25 G2P1L1 NO NO NO YES LN O 4 ABN N N N MAS CPAP 7 DISCHARGE
589 PANDEESWARI 28480 MCH 39 2.17 YES 23 G1 NO NO YES YES LSCS I 4 ABN N N N MAS MV 7 DEATH
590 SOBIYA 28553 FCH 40 2.5 YES 20 G1 ANEMIA NO NO NO LSCS I 5 N N N N BA MV <1 DEATH
591 BISMI 28683 MCH 38 2.5 NO 23 G4P3L2A1 NO NO NO NO LSCS I 3 N N N N TTN HOOD 7 DISCHARGE
592 VEERALAKSHMI 28733 MCH 39 2.71 NO 19 G1 NO NO NO NO LN O 3 ABN N N N PN HOOD 10 DISCHARGE
593 DEVIKA 28922 FCH 39 2.65 YES 20 G1 NO YES YES YES LN O 5 ABN N N N BA CPAP 10 DISCHARGE
594 DHANALAKSHMI 29011 FCH 37 2.5 NO 20 G1 ANEMIA NO NO NO LN O 2 N N N N TTN HOOD 3 DISCHARGE
595 GOWSALYA 29086 MCH 40 3.22 YES 26 G4P1L1A2 ANEMIA NO NO YES LN I 5 ABN N N N MAS CPAP 7 DISCHARGE
596 INBARATHI 29267 FCH 38 2.31 NO 23 G1 NO NO NO NO LN O 4 N POS POS N SEPSIS CPAP 14 DISCHARGE
597 BARGAVI 28874 FCH 40 2.7 NO 23 G1 NO NO NO NO LN I 5 ABN POS POS N SEPSIS CPAP 10 DISCHARGE
598 VISALATCHI 29365 MCH 37 2.8 NO 33 G1 GDM NO NO NO LSCS I 4 N N N PDA CHD CPAP 10 DISCHARGE
599 JEYABHARATHI 29426 MCH 38 2.5 NO 21 G2P1L1 NO NO NO NO LN O 4 N N N N O-CA CPAP 10 DISCHARGE
600 KALPANADEVI 29474 FCH 39 2.6 NO 26 G3P2L1D1 NO NO NO NO LSCS I 3 N N N N TTN HOOD 3 DISCHARGE
601 MAHESWARI 29544 FCH 38 4.5 NO 25 G3P1L1A1 NO NO NO NO LSCS I 4 N N N PDA CHD CPAP 5 DISCHARGE
602 ASWINI 29605 FCH 40 2.6 NO 19 G1 RHD NO NO NO LN I 4 N N N N TTN CPAP 7 DISCHARGE
603 ESWARI 29601 MCH 39 2.6 YES 24 G2P1L1 NO NO NO NO OF I 4 N N N N BA CPAP 7 DISCHARGE
604 ANITHA 29704 MCH 39 1.93 NO 27 G2P1L1 NO NO NO YES LSCS O 5 ABN N N PHHN MAS MV 8 DEATH
605 ANGALESWARI 29743 MCH 40 3.13 NO 23 G3P2L2 NO NO NO NO LN O 6 N POS POS N SEPSIS CPAP 8 DISCHARGE
606 RATHINAPANDI 29846 MCH 38 3.4 NO 28 G1 NO YES NO NO LSCS I 4 N N N PFO CHD CPAP 7 DISCHARGE
607 SELVI 29915 MCH 38 1.86 NO 26 G1 NO NO NO YES LN I 6 ABN N N PPHN MAS CPAP 14 DISCHARGE
608 BENAZIR 29940 FCH 39 2.4 NO 23 G1 NO NO NO NO LSCS I 4 N N N ASD CHD CPAP 4 DISCHARGE
609 JAKKAMMAL 30160 FCH 37 2.15 NO 32 G2A1 PIH NO NO NO LSCS I 4 N N N N TTN CPAP 4 DISCHARGE
610 MEENA 30255 FCH 40 2.75 NO 21 G2A1 ANEMIA NO NO NO LN I 3 N N N N TTN HOOD 3 DISCHARGE
611 RANI 30468 MCH 37 2.35 NO 32 G2P1L1 GDM NO NO NO LSCS I 3 N N N PDA CHD HOOD 3 DISCHARGE
612 KARTHIKA 30517 MCH 38 2.75 YES 21 G1 NO NO NO YES LN O 6 ABN N N N MAS MV 14 DISCHARGE
613 MUTHUSELVI 30770 MCH 37 2.25 NO 23 G2P1L1 NO NO NO NO LSCS I 5 N N N N TTN CPAP 10 DISCHARGE
614 ABIRAMI 30787 MCH 39 2.75 NO 20 G1 NO NO NO YES LN I 5 ABN N N PPHN MAS CPAP 7 DISCHARGE
615 TAMILSELVI 30843 MCH 38 3.2 YES 23 G1 ANEMIA NO NO NO LN O 5 N N N N BA CPAP 10 DISCHARGE
616 MALATHI 30802 FCH 39 2.36 YES 21 G1 PIH YES YES NO LN I 5 N N N N BA CPAP 15 DISCHARGE
617 GAYATHRI 30851 MCH 40 3.7 YES 21 G1 NO NO NO NO LN I 3 N N N N BA HOOD 6 DISCHARGE
618 JEYANTHI 30852 MCH 40 3.1 NO 25 G1 HYPOTY NO NO YES OF I 6 ABN N N N MAS CPAP 14 DISCHARGE
619 VASANTHAMALA 30875 MCH 40 2.75 NO 23 G1 ANEMIA NO NO NO LN I 4 N N N N TTN CPAP 4 DISCHARGE
620 MUTHUMEENA 31002 MCH 40 3.2 NO 19 G1 NO NO NO YES LSCS I 5 ABN N N N MAS CPAP 12 DISCHARGE
621 JEYARANI 31011 MCH 39 2.5 NO 26 G1 NO NO NO NO LSCS I 3 ABN N N TOF CHD HOOD 10 DISCHARGE
622 REKHA 31121 MCH 39 2.8 NO 26 G1 NO NO NO YES LN I 4 ABN N N N MAS CPAP 8 DISCHARGE
623 SHANTHI 31162 MCH 39 3.2 NO 25 G2P1L1 NO NO NO NO LSCS I 3 N N N N TTN HOOD 3 DISCHARGE
624 DURGESHWARI 31177 MCH 38 3.49 YES 19 G1 NO NO NO NO LSCS I 5 N N N N BA CPAP 8 DISCHARGE
625 PAVITHRA 31178 FCH 40 3.4 NO 18 G1 NO NO NO NO LSCS I 4 N N N N TTN CPAP 2 DISCHARGE
626 GANDHIMATHI 31179 FCH 40 3.42 NO 17 G1 NO NO NO NO LSCS I 4 N N N N TTN CPAP 3 DISCHARGE
627 KOKILA 31280 MCH 37 4.025 YES 36 G3P2L2 PIH YES YES YES LSCS I 3 ABN N N N BA HOOD 3 DISCHARGE
628 KARPAGAM 31191 MCH 38 3.42 YES 18 G1 NO NO NO NO LSCS I 4 N N N N BA CPAP 8 DISCHARGE
629 MUNIYAMMAL 31082 MCH 39 3.56 YES 18 G1 NO NO NO NO LSCS I 4 N N N N BA CPAP 12 DISCHARGE
630 MUNEESWARI 31153 MCH 39 2.65 YES 17 G1 NO NO NO NO LSCS I 4 N N N N BA CPAP 3 DISCHARGE
631 VANITHA 31184 MCH 37 2 YES 21 G3P2L2 UTI YES YES YES LSCS O 2 ABN POS POS N SEPSIS HOOD 14 DISCHARGE
632 NAGAMMAL 31285 FCH 39 2.6 NO 17 G1 NO NO NO NO LSCS I 3 N N N N TTN HOOD 3 DISCHARGE
633 MUNIYAMMAL 31245 FCH 39 3.5 NO 17 G1 NO NO NO NO LSCS I 3 N N N N TTN HOOD 3 DISCHARGE
634 NAGAJOTHI 31187 FCH 40 2.7 NO 17 G1 NO NO NO NO LSCS I 2 N N N N TTN HOOD 2 DISCHARGE
635 PANDIYAMMAL 31567 FCH 40 2.95 NO 16 G1 NO NO NO NO LSCS I 3 N N N N TTN HOOD 3 DISCHARGE
636 RAJESWARI 31501 FCH 40 3.3 NO 22 G2A1 NO NO NO NO LSCS O 4 N N N PDA CHD CPAP 9 DISCHARGE
637 JOTHIMANI 31190 MCH 38 4.2 YES 19 G2P1L1 UTI YES YES NO LSCS O 3 N POS POS N SEPSIS HOOD 13 DISCHARGE
638 NAGAJOTHI 31674 MCH 38 2.7 NO 20 G3A2 UTI NO NO NO LSCS O 3 N POS POS N SEPSIS HOOD 12 DISCHARGE
639 GOWSALYA 31192 FCH 40 3.02 NO 18 G1 NO NO NO YES LSCS I 7 ABN N N PPHN MAS MV 3 DEATH
640 KUMUTHA 31899 MCH 37 2.34 YES 37 G2P1L1 UTI NO YES YES LSCS I 2 ABN N N ASD CHD HOOD 3 DISCHARGE
641 AKILA 31194 MCH 38 2.8 NO 24 G3A2 NO NO NO NO LSCS O 4 N N N TR CHD CPAP 7 DISCHARGE
642 JAYAPRIYA 31198 FCH 39 2.9 NO 23 G2P1L1 NO NO NO NO LSCS O 5 N N N ASD CHD CPAP 8 DISCHARGE
643 INDHUMATHI 31796 MCH 38 2.9 NO 27 G2P1L1 NO NO NO NO LSCS O 3 N POS POS N SEPSIS HOOD 14 DISCHARGE
644 SUMITHA 32197 FCH 39 3 NO 28 G2A1 NO NO NO NO LSCS O 4 N POS POS N SEPSIS CPAP 13 DISCHARGE
645 TAMILMANI 31198 FCH 40 3.3 NO 29 G3P2L2 NO NO NO NO LSCS O 5 N POS POS N SEPSIS CPAP 12 DISCHARGE
646 RAMBHA 31579 FCH 40 2.36 NO 30 G2P1L1 GDM NO NO NO LSCS O 5 ABN N N N PN CPAP 14 DISCHARGE
647 JEYAKODI 31200 MCH 38 1.92 NO 19 G3A2 ANEMIA NO NO NO LSCS O 3 N N N N O - CM HOOD 2 DISCHARGE
648 SUGANYA 31201 FCH 39 2.82 NO 20 G2A1 GDM NO NO NO LSCS O 6 ABN N N N O - CLE MV 3 DISCHARGE
649 KAVINILA 31602 MCH 38 4.155 YES 37 G3P1L1A1 GDM YES YES YES LSCS I 2 N N N N BA HOOD 2 DISCHARGE
650 MUMTAJ 31209 MCH 38 2.7 YES 38 G3P2L2 ANEMIA NO NO NO LSCS I 3 N N N N BA HOOD 3 DISCHARGE
651 NAGAJOTHI 31204 MCH 38 2.95 YES 40 G3P2L2 NO NO NO NO LSCS I 4 N N N N BA CPAP 10 DISCHARGE
652 MARIAMMAL 31905 MCH 38 3.4 YES 18 G1 NO NO NO NO LSCS I 4 N N N N BA CPAP 7 DISCHARGE
653 VELMANI 31806 MCH 37 2.44 NO 20 G2A1 ANEMIA NO YES NO LSCS O 3 ABN N N PDA CHD HOOD 2 DISCHARGE
654 VELUTHAI 31201 MCH 38 2.84 NO 22 G3P2L2 PIH NO NO NO LSCS O 3 ABN N N VSD CHD HOOD 3 DISCHARGE
655 VEERACHINNU 31208 MCH 38 2.7 NO 26 G2P1L1 NO NO NO NO LSCS O 2 N N N TAPVC CHD HOOD 3 DISCHARGE
